{
    "testId": 392458686,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 69,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 17,
    "correctToIncorrect": 2,
    "incorrectToCorrect": 3,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 21,
    "averageTimeSpentInSeconds": 89,
    "otherAverageTimeSpentInSeconds": 66,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 25,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 19365,
            "questionIndex": 20850,
            "questionText": "<p>A 10-week-old boy is brought to the clinic for a follow-up visit.&nbsp; He was evaluated in the emergency department 2 weeks ago due to fever.&nbsp; He was well appearing.&nbsp; Laboratory testing revealed leukopenia and anemia.&nbsp; He received empiric antibiotics and was discharged with outpatient follow-up.&nbsp; Bacterial cultures were negative, and his fever resolved.&nbsp; The mother says the patient has been doing well and has continued to normally take soy-based formula feeds.&nbsp; He was born at term, has no other medical conditions, and takes no medications.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 96/62 mm Hg, pulse is 120/min, and respirations are 30/min.&nbsp; Pulse oximetry is 99% on room air.&nbsp; The patient is awake.&nbsp; Physical examination shows no abnormalities.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Complete blood count</td><td style=\"vertical-align:middle;\">2 weeks ago</td><td style=\"vertical-align:middle;\">Today</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">10.3 g/dL</td><td style=\"vertical-align:middle;\">10.1 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td style=\"vertical-align:middle;\">93 &micro;m<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\">95 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Reticulocytes</td><td style=\"vertical-align:middle;\">0.7%</td><td style=\"vertical-align:middle;\">0.8%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">255,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\">255,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">4,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\">6,100/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td style=\"vertical-align:middle;\">71%</td><td style=\"vertical-align:middle;\">63%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td style=\"vertical-align:middle;\">23%</td><td style=\"vertical-align:middle;\">30%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td style=\"vertical-align:middle;\">6%</td><td style=\"vertical-align:middle;\">7%</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s anemia?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T69954\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Physiologic anemia of infancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>&#8593; Tissue oxygenation at birth &#8594; down-regulation of erythropoietin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Asymptomatic term infant* age 2-3 months</li></ul><ul><li>Normocytic anemia (hemoglobin 9-11 g/dL)</li><li>Low to normal reticulocyte count</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment/prognosis</strong></p></td><td><ul><li>Reassurance</li><li>Anemia resolves with &#8593; erythropoietin drive after age 3 months</li></ul></td></tr><tr><td colspan=\"2\"><p>*Preterm infants have a lower nadir at a younger age (ie, anemia of prematurity).</p></td></tr></tbody></table></div><p>This patient had a fever warranting a complete blood count, which revealed anemia and leukopenia.&nbsp; Repeat evaluation shows resolution of the leukopenia, which therefore was likely due to transient bone marrow suppression in the setting of infection.&nbsp; However, this child&#39;s anemia is persistent.&nbsp; In asymptomatic patients <a href=\"46451\">age 2-3 months</a> with a <strong>normocytic</strong> anemia, the most likely cause is <strong>physiologic anemia of infancy</strong>.</p><p>Physiologic anemia of infancy is a transient decline in hemoglobin due to the <strong>down-regulation of erythropoietin</strong> triggered by a sudden increase in tissue oxygenation at birth.&nbsp; Red blood cell production in the bone marrow slows, leading to a <a href=\"44546\">physiologic hemoglobin nadir</a> around 11 g/dL at <strong>age 2-3 months</strong> in term infants (can be as low as 9 g/dL).&nbsp; Although the absolute value of the reticulocyte count may be normal, a compensatory reticulocytosis in response to anemia is absent.&nbsp; After age 2-3 months, the erythropoietin drive returns and hemoglobin levels rise.</p><p>Physiologic anemia of infancy is typically <strong>asymptomatic</strong> but may be identified on laboratory evaluation for other purposes, as in this case.&nbsp; Findings suggestive of a pathologic cause of anemia, such as hemoglobin &lt;9 g/dL, signs of hemolysis (eg, elevated reticulocyte count), or microcytosis, are not present.</p><p><strong>(Choice A)</strong>&nbsp; Iron deficiency (eg, decreased dietary iron, low iron absorption) causes microcytic anemia (ie, low mean corpuscular volume), which is not seen here.&nbsp; This diagnosis is rare before age 4-6 months because iron stores in young infants are derived from the mother in utero.</p><p><strong>(Choices B and C)</strong>&nbsp; Sickle cell disease, associated with intravascular hemolysis, does not cause anemia until age 4-6 months due to the predominance of fetal hemoglobin in young infants.&nbsp; Moreover, this condition and other hemolytic disorders (eg, glucose-6-phosphatase dehydrogenase deficiency, hereditary spherocytosis) cause a compensatory reticulocytosis in the setting of anemia, which is not seen in this patient.&nbsp; In addition, other common hemoglobinopathies (eg, thalassemia) diagnosed by hemoglobin electrophoresis would cause microcytic, not normocytic, anemia.</p><p><strong>Educational objective:</strong><br>Physiologic anemia of infancy is an asymptomatic condition characterized by a normal decrease in hemoglobin with a nadir at age 2-3 months.&nbsp; Pathophysiology involves a transient down-regulation of erythropoietin due to increased tissue oxygenation after birth.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 30293,
            "topic": "Physiologic anemia of infancy",
            "titleId": 30293,
            "title": "Physiologic anemia of infancy",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased dietary iron intake",
                    "choiceNumber": 1,
                    "correctTaken": 3850,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobinopathy",
                    "choiceNumber": 2,
                    "correctTaken": 2930,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravascular hemolysis",
                    "choiceNumber": 3,
                    "correctTaken": 2409,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reduced erythropoietin production",
                    "choiceNumber": 4,
                    "correctTaken": 7396,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1903,2023,true,-1,1*2043,2210,true,-1,1*304,366,true,-1,1*227,238,true,-1,1*1571,1740,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22474117",
                    "mediaDataId": 0,
                    "title": "Anemia in infancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22474117",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 111,
            "othersAvgTimeSpent": 95,
            "notes": null,
            "peopleTaken": 16585,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 775,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 19249,
            "questionIndex": 20733,
            "questionText": "<p>A 5-year-old boy is brought to the emergency department due to an episode of bright-red urine an hour ago.&nbsp; The boy has no chronic medical conditions, but he had nasal congestion, sore throat, and vomiting last week.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 108/66 mm Hg, pulse is 110/min, and respirations are 20/min.&nbsp; The patient is awake and alert.&nbsp; The oropharynx is unremarkable, and the neck is supple with no lymphadenopathy.&nbsp; Cardiopulmonary examination is normal, and the abdomen is soft and nontender.&nbsp; There is no hepatosplenomegaly.&nbsp; Skin examination shows diffuse flat, red pinpoint macules and raised ecchymoses along the lower extremities and trunk.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">9.1 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Reticulocytes</td><td style=\"vertical-align:middle;\">0.1%</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">12,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">1,100/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.5 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Urinalysis</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Protein</td><td style=\"vertical-align:middle;\">none</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocyte esterase</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Nitrites</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Red blood cells</td><td style=\"vertical-align:middle;\">many/hpf</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Casts</td><td style=\"vertical-align:middle;\">none</td></tr></tbody></table>&nbsp;<p>Which of the following is most appropriate in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t66511\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Causes of pancytopenia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Bone marrow aplasia</strong></p></td><td><ul><li>Aplastic anemia</li><li>Infection (eg, parvovirus, HIV, viral hepatitis)</li><li>Nutritional deficiency (eg, vitamin B<sub>12</sub>/folate)</li><li>Medications (eg, hydroxyurea)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Bone marrow infiltration</strong></p></td><td><ul><li>Cancer (eg, hematologic, metastatic)</li><li>Myelofibrosis</li><li>Infection (eg, tuberculosis, fungal infection)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Mature blood cell destruction</strong></p></td><td><ul><li>Intravascular (eg, DIC, TTP)</li><li>Extravascular (eg, hypersplenism)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>DIC</strong> = disseminated intravascular coagulation; <strong>TTP</strong> = thrombotic thrombocytopenic purpura.</p></td></tr></tbody></table></div><p>This boy&#39;s hematuria, ecchymoses, and petechiae (flat pinpoint macules) are likely due to severe <strong>thrombocytopenia</strong>.&nbsp; Concurrent anemia and leukopenia indicate <strong>pancytopenia</strong>, which is typically caused by one of the following:</p><ul><li>Damage to multipotent hematopoietic stem cells in the bone marrow</li><li>Bone marrow infiltration with atypical cells (eg, malignancy) or fibrosis</li><li>Destruction of circulating blood cells (eg, thrombotic microangiopathy, hypersplenism)</li></ul><p>In this patient, the major clue is the <strong>minimal reticulocyte response</strong> despite significant anemia.&nbsp; Although this can be seen in advanced renal disease due to impaired production of erythropoietin, the <strong>normal creatinine</strong> makes significant renal impairment unlikely.&nbsp; Therefore, reticulocytopenia most likely reflects bone marrow failure due to hematologic stem cell damage (eg, <strong>aplastic anemia</strong>) or infiltrative disease (eg, leukemia).</p><p>A peripheral blood smear and <strong>bone marrow evaluation</strong> would likely diagnose his condition:&nbsp; In aplastic anemia, peripheral smear shows a paucity of normal-appearing cells, and bone marrow evaluation reveals a profoundly <strong>hypocellular marrow</strong> with an abundance of fat.&nbsp; In contrast, blast cells on peripheral smear and bone marrow biopsy are indicative of leukemia.</p><p>Aplastic anemia can be idiopathic or due to drugs or viral infections.&nbsp; In addition to manifestations of thrombocytopenia, patients can have recurrent infections (due to neutropenia) or manifestations of anemia (eg, fatigue).</p><p><strong>(Choice A)</strong>&nbsp; Abdominal ultrasound is used to diagnose hypersplenism, which causes low circulating blood cells due to splenic trapping; however, total body cell counts are normal, so symptoms of pancytopenia (eg, bleeding, ecchymoses) are rare.&nbsp; In addition, the lack of splenomegaly on examination makes this unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Bleeding from idiopathic thrombocytopenic purpura (ITP), a condition in which autoantibodies form against platelet surface antigens, is typically treated with intravenous immunoglobulin.&nbsp; ITP can occur after a viral illness, but patients have isolated thrombocytopenia.</p><p><strong>(Choice D)</strong>&nbsp; Plasma exchange treats thrombotic thrombocytopenic purpura, which is characterized by thrombocytopenia due to the formation of intravascular thrombi and microangiopathic hemolytic anemia.&nbsp; However, because the bone marrow is intact, there would be a strong reticulocyte response to the anemia.</p><p><strong>(Choices E and F)</strong>&nbsp; Evaluation of hematuria with serum complement levels (eg, poststreptococcal glomerulonephritis) or kidney biopsy (eg, IgA nephropathy) may be indicated for suspected glomerular disease, particularly with a recent viral illness.&nbsp; However, other laboratory abnormalities (eg, proteinuria, urinary red cell casts, elevated creatinine) and/or examination findings (eg, hypertension, edema) would be expected.&nbsp; Moreover, glomerulonephritis would not explain this patient&#39;s pancytopenia.</p><p><strong>Educational objective:</strong><br>Pancytopenia with a low reticulocyte response indicates a bone marrow condition, and peripheral blood smear and bone marrow evaluation are diagnostic.&nbsp; In aplastic anemia, peripheral smear lacks normal-appearing cells and bone marrow is profoundly hypocellular with abundant fat cells.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3251,
            "topic": "Aplastic anemia",
            "titleId": 3251,
            "title": "Aplastic anemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abdominal ultrasonography",
                    "choiceNumber": 1,
                    "correctTaken": 742,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone marrow evaluation",
                    "choiceNumber": 2,
                    "correctTaken": 7549,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous immunoglobulin therapy",
                    "choiceNumber": 3,
                    "correctTaken": 3025,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma exchange",
                    "choiceNumber": 4,
                    "correctTaken": 1956,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 721,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum complement levels",
                    "choiceNumber": 6,
                    "correctTaken": 2444,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2123,2231,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24424170",
                    "mediaDataId": 0,
                    "title": "Idiopathic aplastic anemia: diagnosis and classification.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24424170",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24237973",
                    "mediaDataId": 0,
                    "title": "Acquired aplastic anemia in children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24237973",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 97,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 16437,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 46,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 687,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 4162,
            "questionIndex": 4162,
            "questionText": "<p>A 32-year-old primigravid woman at 20 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She has no vaginal bleeding, leakage of fluid, or contractions.&nbsp; The patient had mild nausea that resolved at 14 weeks gestation.&nbsp; A fetal anatomical sonogram performed a week ago revealed no abnormalities.&nbsp; The patient has no chronic medical issues or previous surgeries.&nbsp; She is taking a daily prenatal vitamin and does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient works in a laboratory as a biotechnology research assistant.&nbsp; She has blood group O, Rh(D) positive, and her husband has blood group AB, Rh(D) positive.&nbsp; On physical examination, the fundus is palpable at the umbilicus, and the fetal heart rate is 140/min.&nbsp; The patient is concerned about different blood groups and the risk of pregnancy complications.&nbsp; Which of the following is the most appropriate response to this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32548\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>ABO hemolytic disease </strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors </strong></p></td><td><ul><li>Infants with blood types A or B born to a mother with blood type O</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features </strong></p></td><td><ul><li>Jaundice within 24 hours of birth</li><li>Anemia</li><li>&#8593; Reticulocyte count</li><li>Hyperbilirubinemia</li><li>Positive Coombs test</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management </strong></p></td><td><ul><li>Serial bilirubin levels, oral hydration &amp; phototherapy for most neonates</li><li>Exchange transfusion for severe anemia/hyperbilirubinemia</li></ul></td></tr></tbody></table></div><p>This patient with blood group O, whose husband is blood group AB, will bear a child with either blood group A or B.&nbsp; In these situations of <strong>ABO incompatibility</strong>, signs of hemolytic disease are typically <strong>mild</strong> and apparent only in approximately one-third of infants.&nbsp; Affected infants are usually <strong>asymptomatic</strong> or <strong>mildly anemic</strong> at birth; within the first 24 hours of life they may develop <strong>jaundice</strong> (eg, hyperbilirubinemia), which typically responds to <strong>phototherapy</strong>.</p><p>A pregnant woman&#39;s immune system is not depressed overall; interaction between the innate (eg, neutrophils, macrophages) and adaptive (eg, antibodies) immune systems allows for an appropriate response at the fetal-maternal interface <strong>(Choice D)</strong>.&nbsp; Exposure to the A and B antigens of the fetus does provoke an IgM response during pregnancy, but these antibodies are large pentamers that cannot cross the placenta <strong>(Choice E)</strong>.&nbsp; However, patients with blood group O are exposed to A and B antigens early in life (from exposure to A- and B-like antigens present in food, bacteria, and viruses) and produce antibodies to these antigens.&nbsp; By the time a woman with blood group O becomes pregnant, she already has anti-A and anti-B IgG antibodies that cross the placenta; therefore, ABO incompatibility can affect a first pregnancy <strong>(Choice A)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Antibodies against A and B are hemolytic.&nbsp; However, in addition to red blood cells, A and B antigens are present on the cells of all other fetal tissues.&nbsp; The reaction of the anti-A and anti-B antibodies with the antigens on these other cells neutralizes the antibody response, leading to a much milder form of hemolytic disease.</p><p><strong>Educational objective:</strong><br>ABO incompatibility typically occurs between a mother with blood group O and an infant with blood group A or B, which can cause mild hemolytic disease of the newborn.&nbsp; Affected infants are usually asymptomatic at birth or have mild anemia, and may develop neonatal jaundice that typically responds to phototherapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 23743,
            "topic": "Abo incompatibility",
            "titleId": 23743,
            "title": "Abo incompatibility",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "&#x22;ABO antigens elicit only an IgM response, so you are not at risk with this pregnancy.&#x22;",
                    "choiceNumber": 1,
                    "correctTaken": 3198,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Antibodies to ABO antigens are not hemolytic.&#x22;",
                    "choiceNumber": 2,
                    "correctTaken": 936,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;Most newborns affected by ABO incompatibility will have only mild hemolytic disease.&#x22;",
                    "choiceNumber": 3,
                    "correctTaken": 7559,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;You are not at risk as the immune response is depressed during pregnancy.&#x22;",
                    "choiceNumber": 4,
                    "correctTaken": 311,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "&#x22;You are tolerant to your child&#39;s ABO antigens, so your newborn will not have hemolytic disease.&#x22;",
                    "choiceNumber": 5,
                    "correctTaken": 4759,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1705,2035,true,-1,1*1281,1681,true,-1,1*234,254,true,-1,1*340,397,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26491605",
                    "mediaDataId": 0,
                    "title": "Estimating the risk of ABO hemolytic disease of the newborn in Lagos.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26491605",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 92,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16763,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 455,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 4859,
            "questionIndex": 4859,
            "questionText": "<p>A 55-year-old woman comes to the office due to right leg swelling and tenderness.&nbsp; She has a history of ovarian cancer and is currently undergoing chemotherapy.&nbsp; A duplex venous ultrasound of the right lower extremity shows thrombosis of the right popliteal vein.&nbsp; The patient is sent home with subcutaneous enoxaparin.&nbsp; A week later, the patient returns to the office for a follow-up appointment.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\"><tbody><tr><td></td><td width=\"33%\"><strong>At Discharge</strong></td><td width=\"33%\"><strong>Now</strong></td></tr><tr><td>Hematocrit</td><td>44%</td><td>43%</td></tr><tr><td>Leukocytes</td><td>6,500/mm<sup><font>3</font></sup></td><td>6,100/mm<sup><font>3</font></sup></td></tr><tr><td>Platelets</td><td>210,000/mm<sup><font>3</font></sup></td><td>70,000/mm<sup><font>3</font></sup></td></tr><tr><td>INR</td><td>0.9</td><td>1.0</td></tr></tbody></table></blockquote><p>This patient&#39;s current condition predisposes her to which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"4696\"  src=\"https://www.uworld.com/media/L12001.png\" draggable=\"false\" ></p><p>This patient was initiated on low molecular weight <strong>heparin</strong> (enoxaparin) due to an acute deep venous thrombosis.&nbsp; A week later, laboratory studies show a significant reduction in platelet count, suggesting type 2 <strong>heparin-induced thrombocytopenia</strong> (HIT).&nbsp; A drop in platelets by <strong>&gt;50%</strong> or a new thrombus within <strong>5-10 days</strong> of heparin initiation should raise suspicion for HIT (HIT may manifest sooner in patients previously exposed to heparin).</p><p>Heparin induces a conformational change to a platelet surface protein (platelet factor 4 [PF4]), which creates a neoantigen.&nbsp; In patients with HIT, the immune system responds by forming an IgG autoantibody (HIT antibody).&nbsp; HIT antibodies then coat the surface of platelets, causing:</p><ul><li><strong>Thrombocytopenia</strong> - the reticuloendothelial system (largely the spleen) removes HIT antibody-coated platelets, causing mild to moderate thrombocytopenia (mean nadirs of 60,000/mm<font size=\"2\"><sup>3</sup></font>).&nbsp; Severe thrombocytopenia (&lt;20,000/mm<font size=\"2\"><sup>3</sup></font>) is uncommon.</li><li><strong>Thrombus</strong> - HIT antibodies activate platelets, resulting in platelet aggregation and the release of procoagulant factors.&nbsp; This puts patients at very high risk (as high as 50%) for <strong>arterial and venous thrombus</strong>.&nbsp; Venous thrombosis in the leg veins, cardiac vessels, and skin (at the site of heparin injection) is common.&nbsp; Arterial thrombosis may occur in the heart, limbs, or central nervous system.</li></ul><p>If HIT is suspected, all heparin products should be <strong>discontinued immediately</strong> and <strong>anticoagulation</strong> should be initiated with a non-heparin medication (eg, argatroban, fondaparinux).&nbsp; Diagnosis is confirmed by functional assay (eg, serotonin-release assay [gold standard]) or high-titer immunoassay of the blood.</p><p><strong>(Choice A)</strong>&nbsp; Acute interstitial nephritis (AIN) presents with renal dysfunction and is typically caused by medications, autoimmune disorders (eg, systemic lupus erythematosus), or infections.&nbsp; Heparin is not commonly associated with AIN.</p><p><strong>(Choice C)</strong>&nbsp; Coronary vasospasm is caused by hyperreactivity of the coronary vessels and may result in anginal symptoms.&nbsp; Patients with HIT are at risk for venous and arterial thrombus in the coronary vessels (not vasospasm).</p><p><strong>(Choice D)</strong>&nbsp; Hemarthrosis is usually due to trauma (most common), vascular damage, or coagulopathy (eg, hemophilia).&nbsp; It is uncommon for HIT to cause bleeding issues.</p><p><strong>(Choice E)</strong>&nbsp; Mycotic aneurysms are bacterial infections of the vascular wall that tend to occur after trauma or with preexisting aneurysm.&nbsp; Deep venous thrombosis typically does not put patients at increased risk for a mycotic aneurysm.</p><p><strong>Educational objective:</strong><br>Heparin-induced thrombocytopenia (HIT) is an immune-mediated process that causes thrombocytopenia several days after initiation of heparin therapy.&nbsp; HIT is highly thrombogenic and patients must be placed on alternate forms of anticoagulation due to the risk for arterial and venous clots.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7111,
            "topic": "Heparin induced thrombocytopenia",
            "titleId": 7111,
            "title": "Heparin induced thrombocytopenia",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute interstitial nephritis",
                    "choiceNumber": 1,
                    "correctTaken": 1114,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Arterial thrombosis",
                    "choiceNumber": 2,
                    "correctTaken": 12286,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Coronary vasospasm",
                    "choiceNumber": 3,
                    "correctTaken": 540,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemarthrosis",
                    "choiceNumber": 4,
                    "correctTaken": 8941,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mycotic aneurysm",
                    "choiceNumber": 5,
                    "correctTaken": 488,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1384,1692,true,-1,1*284,469,true,-1,1*1196,1383,true,-1,1*470,752,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22399304",
                    "mediaDataId": 0,
                    "title": "Heparin-induced thrombocytopenia: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22399304",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 42,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 23369,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 915,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 2597,
            "questionIndex": 2597,
            "questionText": "<p>A 74-year-old man comes to the office due to 3 months of &#x22;problems of old age.&#x22;&nbsp; He has daily temporal headaches and feels quite fatigued.&nbsp; Intermittently, the patient&#39;s ears ring and his eyes become blurry.&nbsp; Both feet feel as if someone is &#x22;sticking them with electric pins.&#x22;&nbsp; The patient used to smoke cigarettes but now uses vaporized nicotine.&nbsp; His medical history is unremarkable.&nbsp; Temperature is 36.6 C (97.8 F), blood pressure is 128/74 mm Hg, and pulse is 88/min.&nbsp; He is well appearing.&nbsp; There is moderate cervical lymphadenopathy.&nbsp; Cardiopulmonary examination is normal.&nbsp; Hepatosplenomegaly is present.&nbsp; Funduscopy shows dilated, segmented, and tortuous retinal veins.&nbsp; There are sensory deficits in his feet, but reflexes and strength are intact.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>9.6 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>136,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>6,200/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>108 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>141 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.6 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>18 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.9 mg/dL</td></tr></tbody></table><p>Serum protein electrophoresis reveals a sharp IgM spike.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t81585\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Waldenstr</strong><strong>&ouml;m macroglobulinemia vs multiple myeloma</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Waldenstr&ouml;m macroglobulinemia</strong></p></td><td><p align=\"center\"><strong>Multiple myeloma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Major manifestations</strong></p></td><td><ul><li>Hyperviscosity syndrome</li><li>Neuropathy</li><li>Bleeding</li><li>Hepatosplenomegaly</li><li>Lymphadenopathy</li></ul></td><td><ul><li>Osteolytic lesions/fractures</li><li>Anemia</li><li>Hypercalcemia</li><li>Renal insufficiency</li></ul></td></tr><tr><td><p align=\"center\"><strong>Monoclonal antibody</strong></p></td><td><ul><li>IgM</li></ul></td><td><ul><li>IgG, IgA, light chains</li></ul></td></tr><tr><td><p align=\"center\"><strong>Peripheral smear</strong></p></td><td><ul><li>Rouleaux</li></ul></td><td><ul><li>Rouleaux</li></ul></td></tr><tr><td><p align=\"center\"><strong>Bone marrow biopsy</strong></p></td><td><ul><li>&gt;10% clonal B cells</li></ul></td><td><ul><li>&gt;10% clonal plasma cells</li></ul></td></tr></tbody></table></div></p><p><strong>Waldenstrom macroglobulinemia (WM)</strong> is a lymphoplasmocytic malignancy characterized by the excessive production of <strong>monoclonal IgM antibody</strong>.&nbsp; Clinical manifestations of WM stem from elevated serum IgM (hyperviscosity syndrome, neuropathy, cryoglobulinemia) and neoplastic infiltration of tissue (hepatosplenomegaly, lymphadenopathy, cytopenias).&nbsp; Peripheral blood smear may show rouleaux formation (or <a href=\"5014\">erythrocyte agglutination</a>) due to elevated serum protein.&nbsp; Serum protein electrophoresis (SPEP) is an important screening study; patients with WM have a monoclonal spike (<strong>M-spike</strong>) of IgM.&nbsp; Diagnosis is then confirmed by bone marrow biopsy showing <strong>&gt;10% clonal B cells</strong> with specific cytogenetic features.</p><p>This patient presents with manifestations of <strong>hyperviscosity syndrome</strong> (diplopia, tinnitus, headache, dilated/segmented funduscopic findings), <strong>neuropathy</strong> (electric sensation), and evidence of <strong>infiltrative</strong> disease (hepatosplenomegaly, anemia, thrombocytopenia), suggesting WM.</p><p><strong>(Choice A)</strong>&nbsp; A minority of patients with chronic lymphocytic leukemia (CLL) have high levels of monoclonal IgM.&nbsp; However, patients with CLL tend to have a dramatic lymphocytic predominant leukocytosis (often &gt;100,000/mm<font size=\"2\"><sup>3</sup></font>) on complete blood count.</p><p><strong>(Choice B)</strong>&nbsp; Patients with monoclonal gammopathy of undetermined significance (MGUS) also have M spikes, but they are most commonly due to IgA, IgG, or IgD (IgM is seen in 15% of cases).&nbsp; MGUS is marked by smaller M spikes (&lt;3 g/dL), bone marrow biopsy with &lt;10% monoclonal plasma cells, and, unlike this patient, no end-organ effects (no anemia, hepatosplenomegaly, lymphadenopathy, or systemic symptoms).</p><p><strong>(Choice C)</strong>&nbsp; Multiple myeloma (MM) is also a plasma cell neoplasm that produces a monoclonal antibody spike by SPEP; however, patients with MM rarely (&lt;0.5%) produce monoclonal IgM.&nbsp; MM is typically characterized by monoclonal IgG, IgA, or light chains.&nbsp; In addition, patients with MM tend to present with bone pain rather than hyperviscosity, neuropathy, and tissue infiltration.</p><p><strong>(Choice D)</strong>&nbsp; Non-Hodgkin lymphoma (NHL) usually presents with lymphadenopathy, splenomegaly, and B symptoms (fevers, night sweats, weight loss).&nbsp; SPEP tends not to show monoclonal spikes with NHL.&nbsp; In addition, hyperviscosity syndrome is not a feature of this disease.</p><p><strong>Educational objective:</strong><br>Waldenstrom macroglobulinemia (WM) is a lymphoplasmocytic neoplasm characterized by excessive monoclonal IgM, end-organ damage, and &gt;10% clonal lymphocytes by bone marrow biopsy.&nbsp; Hyperviscosity syndrome, neuropathy, and cryoglobulinemia are common consequences of elevated serum IgM in patients with WM.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 9166,
            "topic": "Waldenstrm macroglobulinemia",
            "titleId": 9166,
            "title": "Waldenstrm macroglobulinemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic lymphocytic leukemia",
                    "choiceNumber": 1,
                    "correctTaken": 159,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Monoclonal gammopathy of undetermined significance",
                    "choiceNumber": 2,
                    "correctTaken": 2486,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Multiple myeloma",
                    "choiceNumber": 3,
                    "correctTaken": 2860,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Non-Hodgkin lymphoma",
                    "choiceNumber": 4,
                    "correctTaken": 143,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Waldenstrom macroglobulinemia",
                    "choiceNumber": 5,
                    "correctTaken": 10082,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "251",
                    "mediaDataId": 0,
                    "title": "Waldenstrm macroglobulinemia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 108,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 15730,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 26,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 18487,
            "questionIndex": 19957,
            "questionText": "<p>A 24-year-old woman is brought to the emergency department (ED) after a motor vehicle collision.&nbsp; She was the passenger in a vehicle that collided with an 18-wheeler.&nbsp; Paramedics state that the patient was ejected from the vehicle and found on the side of the road.&nbsp; They placed 2 large-bore intravenous lines, infused 1 L of crystalloid, and transported her to the ED.&nbsp; Blood pressure is 80/50 mm Hg, pulse is 138/min, and respirations are 24/min.&nbsp; On examination, the eyes are closed, and the patient is moaning.&nbsp; Auscultation of the lungs reveals decreased breath sounds on the right.&nbsp; The abdomen is tender in the right and left upper quadrants.&nbsp; The patient has an obvious deformity of the left thigh.&nbsp; The extremities are cold and clammy.&nbsp; Chest x-ray reveals a right hemothorax.&nbsp; Focused assessment with sonography for trauma examination shows evidence of free fluid in the right and left upper quadrants.&nbsp; A right chest tube is placed, and 1.5 L of blood is returned.&nbsp; Which of the following is the best next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t63357\"><table class=\"table-default-style table-header-footer-style\" style=\"width:96.26%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Management of hemorrhage due to trauma</strong></p></td></tr><tr><td style=\"width: 22%;\"><p align=\"center\"><strong>Control<br />bleeding</strong></p></td><td style=\"width: 78%;\"><ul><li>Control bleeding from any compressible site</li><li>Early transfer to location (trauma center, operating room, angiography suite) for definitive care &amp; control of hemorrhage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Give blood<br />products early</strong></p></td><td><ul><li>Transfuse blood products early in resuscitation</li><li>Massive transfusion protocol*: ratio of 1:1:1 FFP/pRBCs/platelets to minimize risk of coagulopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Limit use of&nbsp;crystalloids</strong></p></td><td><ul><li>Limit to ~1 L if patient is hypotensive</li><li>Switch to blood products as soon as available</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>*</strong>Massive transfusion protocol likely required in patients with &ge;2 of the following: SBP&nbsp;&le;90&nbsp;mm Hg, pulse&nbsp;&ge;120/min, positive FAST examination, and penetrating mechanism of injury.</p><p><strong>FAST</strong> = Focused Assessment with Sonography for Trauma; <strong>FFP</strong>&nbsp;=&nbsp;fresh frozen plasma; <strong>pRBCs</strong>&nbsp;=&nbsp;packed red blood cells; <strong>SBP</strong> = systolic blood pressure.</p></td></tr></tbody></table></div><p>This patient has multiple sites for <strong>blood loss</strong>: hemothorax (decreased breath sounds, 1.5 L of blood from chest tube), hemoperitoneum (tender abdomen, positive focused assessment with sonography for trauma [FAST] examination), and femur fracture (left thigh deformity).&nbsp; In the setting of blood loss, a systolic blood pressure (SBP) <strong>&lt;90 mm Hg</strong>, along with tachycardia &gt;120/min, altered mental status (eyes closed, moaning), and delayed capillary refill (cold, clammy extremities), suggests at least <strong>30% loss of circulating blood volume</strong>, generally classified as class III hemorrhage.&nbsp; This presentation is consistent with <strong>hemorrhagic shock</strong> from bleeding at noncompressible sites (chest and abdomen).</p><p>Type-specific blood is the optimal choice for transfusion; however, depending on several factors (eg, trauma vs nontrauma center, presence of antibodies), it can take significant (eg, &gt;20 min) time to prepare (eg, after type and cross-matching).&nbsp; Patients in hemorrhagic shock, such as this one, can exsanguinate in that time <strong>(Choice E)</strong>.&nbsp; Therefore, in such situations, <strong>group O, Rh D-negative blood</strong> should be administered unless type-specific blood is immediately available.</p><p>Most hospitals keep O Rh D-negative blood (universal donor) ready for use in emergencies.&nbsp; To prevent <a href=\"1151\">hemolytic disease of the newborn</a> in future pregnancies, it is particularly important that this type of blood be given to women of <strong>childbearing age</strong>, as in this patient, and to young girls.&nbsp; In men and in women past childbearing age, O Rh D-positive blood can be given <strong>(Choice D)</strong>.</p><p>When there is concern for massive transfusion requirements (eg, SBP &#8804;90/mm Hg, pulse &#8805;120/min, positive FAST, penetrating mechanism of injury), blood products should be given in a 1:1:1 fresh frozen plasma/packed red blood cells/platelets ratio to minimize risk of coagulopathy (eg, widespread tissue damage, lactic acidosis).</p><p><strong>(Choice A)</strong>&nbsp; In acutely injured trauma patients, excess crystalloid use exacerbates the lethal, trauma-induced triad of hypothermia, acidosis, and coagulopathy, increasing mortality.&nbsp; Research supports limited crystalloid administration (eg, 1 L) in patients with hemorrhagic shock when blood is not immediately available.</p><p><strong>(Choice B)</strong>&nbsp; Vasopressors are appropriate for patients with severe peripheral vasodilation due to distributive (eg, septic, neurogenic) shock.&nbsp; Patients with hemorrhagic shock should receive volume resuscitation with blood transfusion while awaiting definitive management of the hemorrhage (eg, surgical intervention).&nbsp; Vasopressor administration without appropriate resuscitation can worsen tissue perfusion.</p><p><strong>Educational objective:</strong><br>Blood transfusion should be initiated early in patients with hemorrhagic shock.&nbsp; Group O, Rh D-negative blood (universal donor) should be transfused while waiting for type-specific blood to be available.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 19726,
            "topic": "Hypovolemic shock",
            "titleId": 19726,
            "title": "Hypovolemic shock",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer an additional liter of crystalloid",
                    "choiceNumber": 1,
                    "correctTaken": 1503,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Administer a vasopressor",
                    "choiceNumber": 2,
                    "correctTaken": 905,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transfuse group O, Rh D-negative packed red blood cells",
                    "choiceNumber": 3,
                    "correctTaken": 13306,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transfuse group O, Rh D-positive packed red blood cells",
                    "choiceNumber": 4,
                    "correctTaken": 670,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transfuse type-specific packed red blood cells after type and cross-matching",
                    "choiceNumber": 5,
                    "correctTaken": 1235,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "326,424,true,-1,1*451,490,true,-1,1*2751,2921,true,-1,1*2032,2401,true,-1,1*1338,1439,true,-1,1*2413,2739,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25535421",
                    "mediaDataId": 0,
                    "title": "Massive transfusion and massive transfusion protocol.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25535421",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 113,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 17619,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1427,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 22967,
            "questionIndex": 107069,
            "questionText": "<p>A 52-year-old woman is hospitalized for induction chemotherapy to treat acute myeloid leukemia.&nbsp; The patient has no prior medical concerns.&nbsp; She had been experiencing worsening fatigue, dyspnea, and exercise intolerance.&nbsp; Evaluation revealed anemia, thrombocytopenia, and leukocytosis with circulating myeloblasts.&nbsp; Bone marrow biopsy established the diagnosis of acute myeloid leukemia.&nbsp; Pretreatment medical evaluation showed no abnormalities.&nbsp; The day following chemotherapy, laboratory results reveal the following:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Sodium</td><td style=\"vertical-align:middle;\">136 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Potassium</td><td style=\"vertical-align:middle;\">5.7 mEq/L</td></tr><tr><td style=\"padding-left: 2em;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">20 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Calcium</td><td style=\"vertical-align:middle;\">7.0 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Phosphorus</td><td style=\"vertical-align:middle;\">7.2 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Lactate dehydrogenase</td><td style=\"vertical-align:middle;\">984 U/L</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">Uric acid</td><td style=\"vertical-align:middle;\">11.2 mg/dL</td></tr></tbody></table><p>In addition to intravenous hydration, which of the following is the best treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31451\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Tumor lysis syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk</strong></p></td><td><ul><li>Tumors with high cell burden or rapid turnover</li><li>Combination chemotherapy/immunotherapy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Severe electrolyte abnormalities<ul style=\"list-style-type:circle;\"><li>&#8593; Phosphorus, potassium, uric acid</li><li>&#8595; Calcium</li></ul></li><li>Acute kidney injury</li><li>Cardiac arrhythmias</li><li>Seizures</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prophylaxis</strong></p></td><td><ul><li>Intravenous fluids</li><li>Xanthine oxidase inhibitor* or rasburicase</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Intravenous fluids + rasburicase</li><li>Continuous telemetry</li><li>Aggressive electrolyte monitoring &amp; treatment</li></ul></td></tr><tr><td colspan=\"2\"><p>*Allopurinol or febuxostat.</p></td></tr></tbody></table></div><p>This patient has developed significant laboratory abnormalities (eg, hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia) a day following <strong>chemotherapy</strong>, indicating <strong>tumor lysis syndrome</strong> (TLS).&nbsp; TLS typically develops in patients who have tumors with high cell burden or rapid cellular turnover (eg, <strong>acute leukemia</strong>) and is characterized by <a href=\"34331\">rapid release</a> of intracellular potassium, phosphate, and <strong>nucleic acids</strong> into the circulation.</p><p>Phosphate binds up calcium to cause hypocalcemia, and purine nucleic acids are <strong>metabolized</strong> into <strong>uric acid</strong> (ie, urate) by xanthine oxidase, leading to hyperuricemia and risk of acute kidney injury (AKI) due to renal tubular crystal deposition.&nbsp; This risk can be reduced by pretreatment with intravenous fluids and <strong>urate-lowering therapy</strong> consisting of medications that perform the following:</p><ul><li><strong>Reduce new urate formation:</strong>&nbsp; xanthine oxidase inhibitors (eg, allopurinol, febuxostat)</li><li><strong>Directly break down urate:</strong>&nbsp; recombinant urate oxidase analogues (eg, rasburicase)</li></ul><p>Xanthine oxidase inhibitors are commonly given in conjunction with intravenous fluids <em>prior</em> to chemotherapy to reduce urate formation.&nbsp; However, in this patient with hyperuricemia and evidence of TLS following chemotherapy, xanthine oxidase inhibition (eg, with allopurinol) would not be effective because it does not eliminate urate that has already formed <strong>(Choice A)</strong>.&nbsp; Urate oxidase <a href=\"53792\">breaks down urate</a> to reduce hyperuricemia that has already developed, making <strong>rasburicase</strong> the preferred urate-lowering therapy for the treatment of TLS.</p><p><strong>(Choice B)</strong>&nbsp; Hemodialysis is usually needed only in patients with TLS who have severe AKI and electrolyte derangements that are refractory to medical treatment.&nbsp; This patient with normal renal function should receive medical treatment with intravenous fluids and rasburicase.</p><p><strong>(Choice C)</strong>&nbsp; In addition to treatment of hyperuricemia, patients with TLS should undergo monitoring of other electrolyte derangements (eg, hyperkalemia, hyperphosphatemia, hypocalcemia) and treatment if necessary.</p><p><strong>(Choice E)</strong>&nbsp; Urinary alkalinization prior to chemotherapy theoretically reduces renal tubular precipitation of urate by increasing its solubility.&nbsp; However, this is not routinely performed due to a lack of evidence and the potential risk of promoting calcium phosphate deposition in the renal tubules (ie, nephrocalcinosis).</p><p><strong>Educational objective:</strong><br>Tumor lysis syndrome can occur after chemotherapy and results in significant elevations in serum potassium, phosphate (with decreased serum calcium), and uric acid (ie, urate).&nbsp; In patients with preexisting hyperuricemia or in those who develop hyperuricemia following chemotherapy, the administration of rasburicase directly breaks down urate and rapidly lowers its serum concentration.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 19803,
            "topic": "Tumor lysis syndrome",
            "titleId": 19803,
            "title": "Tumor lysis syndrome",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Allopurinol",
                    "choiceNumber": 1,
                    "correctTaken": 1652,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemodialysis",
                    "choiceNumber": 2,
                    "correctTaken": 565,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional therapy",
                    "choiceNumber": 3,
                    "correctTaken": 227,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rasburicase",
                    "choiceNumber": 4,
                    "correctTaken": 2106,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinary alkalinization",
                    "choiceNumber": 5,
                    "correctTaken": 467,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2530,2842,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "520",
                    "mediaDataId": 0,
                    "title": "Tumor lysis syndrome (TLS)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28203093",
                    "mediaDataId": 0,
                    "title": "Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28203093",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 94,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 5017,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 42,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 535,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 14271,
            "questionIndex": 15679,
            "questionText": "<p>A 30-year-old man is admitted for observation following a motorcycle collision.&nbsp; He was hemodynamically stable at presentation, and the initial workup revealed an isolated liver laceration.&nbsp; The patient has no chronic medical conditions and takes no medications.&nbsp; He consumes 3-4 alcoholic drinks daily and has been smoking 1 pack of cigarettes daily for the past 10 years.&nbsp; Overnight, his hemoglobin levels acutely decreased, and a packed red blood cell transfusion was ordered.&nbsp; An hour after the transfusion starts, the patient develops difficulty breathing.&nbsp; The transfusion is stopped.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 86/42 mm Hg, pulse is 110/min, and respirations are 26/min.&nbsp; Pulse oximetry shows 88% on room air.&nbsp; Lung examination reveals bilateral crackles.&nbsp; Skin examination is normal.&nbsp; Chest x-ray reveals bilateral pulmonary infiltrates.&nbsp; Which of the following is the best next step in management of this patient&#39;s respiratory distress?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t48544\"><table class=\"table-default-style table-footer-only-style\" style=\"width:89.16%\"><tbody><tr><td colspan=\"4\" style=\"width:100.0%\"><p align=\"center\"><strong>Transfusion reactions associated with hypotension</strong></p></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Reaction</strong></p></td><td style=\"width:17.2%\"><p align=\"center\"><strong>Onset*</strong></p></td><td style=\"width:23.52%\"><p align=\"center\"><strong>Cause</strong></p></td><td style=\"width:35.92%\"><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Anaphylaxis</strong></p></td><td style=\"width:17.2%\"><p align=\"center\">Seconds to minutes</p></td><td style=\"width:23.52%\"><p align=\"center\">Recipient anti-IgA antibodies</p></td><td style=\"width:35.92%\"><ul><li>Shock, angioedema/urticaria &amp; respiratory distress</li></ul></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Transfusion-related acute lung injury</strong></p></td><td style=\"width:17.2%\"><p align=\"center\">Minutes to hours</p></td><td style=\"width:23.52%\"><p align=\"center\">Donor antileukocyte antibodies</p></td><td style=\"width:35.92%\"><ul><li>Respiratory distress &amp; noncardiogenic pulmonary edema</li><li>Bilateral pulmonary infiltrates</li></ul></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Acute hemolysis</strong></p></td><td style=\"width:17.2%\"><p align=\"center\">Minutes to hours</p></td><td style=\"width:23.52%\"><p align=\"center\">ABO incompatibility</p></td><td style=\"width:35.92%\"><ul><li>Fever, flank pain, hemoglobinuria &amp; DIC</li></ul></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Bacterial sepsis</strong></p></td><td style=\"width:17.2%\"><p align=\"center\">Minutes to hours</p></td><td style=\"width:23.52%\"><p align=\"center\">Bacterial contamination of donor product</p></td><td style=\"width:35.92%\"><ul><li>Fever, chills, septic shock &amp; DIC</li></ul></td></tr><tr><td colspan=\"4\" style=\"width:100.0%\"><p>*Time after transfusion initiation.</p><p><strong>DIC</strong> = disseminated intravascular coagulation.</p></td></tr></tbody></table></div><p>This patient developed respiratory distress, hypotension, and pulmonary infiltrates during blood transfusion, findings concerning for <strong>transfusion-related acute lung injury (TRALI)</strong>.&nbsp; TRALI is an uncommon but <strong>potentially fatal</strong> transfusion reaction in which neutrophils activated by a component in the transfused blood (eg, anti-leukocyte antibodies) cause damage to pulmonary microvasculature.&nbsp; Risk factors for TRALI include smoking, alcohol use disorder, and critical illness.</p><p>Damage to the capillary endothelium results in <strong>inflammatory pulmonary edema</strong>.&nbsp; Hypoxia and <strong>dyspnea</strong> develop within 6 hours after transfusion initiation.&nbsp; Tachycardia, <strong>hypotension</strong>, and fever may also be present.&nbsp; Chest x-ray reveals <strong>bilateral pulmonary infiltrates</strong>.</p><p>Treatment of TRALI includes immediate transfusion cessation and <strong>respiratory supportive care</strong>; most patients require ventilatory support.&nbsp; Some patients recover within 24-48 hours, but the mortality rate is about 50% in previously critically ill patients.</p><p><strong>(Choice A)</strong>&nbsp; Anticoagulation is indicated for pulmonary embolism, which causes tachycardia and hypoxia.&nbsp; Bilateral pulmonary infiltrates would be unusual, and the temporal association with transfusion makes TRALI more likely.</p><p><strong>(Choice B)</strong>&nbsp; Broad-spectrum antibiotics are administered for transfusion-transmitted bacterial infection, which most commonly occurs after platelet transfusion and presents with fever, rigors, tachycardia, and hypotension.&nbsp; This patient&#39;s pulmonary findings and lack of fever make this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Diuretic therapy is the treatment for transfusion-associated circulatory overload (TACO).&nbsp; Patients have respiratory distress within 6 hours after transfusion initiation; however, hypertension due to fluid overload is typically present.&nbsp; In addition, this patient has not received a significant amount of fluid, making TACO less likely.</p><p><strong>(Choice D)</strong>&nbsp; In addition to intramuscular epinephrine, intravenous antihistamine administration is indicated in anaphylactic transfusion reactions, which can present with respiratory distress and hypotension.&nbsp; However, anaphylaxis occurs within minutes after transfusion initiation.&nbsp; Moreover, examination typically reveals wheezing (not crackles), and pulmonary infiltrates would not be seen.</p><p><strong>Educational objective:</strong><br>Transfusion-related acute lung injury is a potentially fatal transfusion reaction, presenting with acute dyspnea and hypoxia, bilateral pulmonary infiltrates, and possible hypotension.&nbsp; Management involves transfusion cessation and respiratory supportive care.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3303,
            "topic": "Blood transfusion",
            "titleId": 3303,
            "title": "Blood transfusion",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anticoagulation therapy",
                    "choiceNumber": 1,
                    "correctTaken": 634,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Broad-spectrum antibiotics",
                    "choiceNumber": 2,
                    "correctTaken": 200,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diuretic therapy",
                    "choiceNumber": 3,
                    "correctTaken": 1768,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intravenous antihistamines",
                    "choiceNumber": 4,
                    "correctTaken": 3832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Respiratory supportive care only",
                    "choiceNumber": 5,
                    "correctTaken": 10016,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1918,2128,true,-1,1*870,1314,true,-1,1*151,179,true,-1,1*287,317,true,-1,1*492,496,true,-1,1*602,605,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31559068",
                    "mediaDataId": 0,
                    "title": "Blood transfusion associated lung injury.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31559068",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 16450,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 759,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 16233,
            "questionIndex": 17675,
            "questionText": "<p>A 50-year-old woman is evaluated in the post-anesthesia care unit due to sudden onset of severe nausea and right flank pain.&nbsp; The patient underwent a total abdominal hysterectomy and tumor debulking for metastatic ovarian cancer.&nbsp; The procedure was complicated by bleeding and a ureteral laceration that was repaired intraoperatively.&nbsp; Immediately afterwards, her hemoglobin level was 6.8 g/dL.&nbsp; A packed red blood cell transfusion was initiated 10 minutes ago.&nbsp; Now, in addition to nausea and right flank pain, she has developed pain and oozing along the IV site.&nbsp; Temperature is 38.5 C (101.3 F), blood pressure is 90/50 mm Hg, pulse is 130/min, and respirations are 26/min.&nbsp; Cardiac examination reveals tachycardia with weak pulses.&nbsp; The lungs are clear bilaterally.&nbsp; The skin examination is normal.&nbsp; The urine is dark red.&nbsp; Which of the following would most likely establish the diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t56352\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute hemolytic transfusion reaction</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>ABO incompatibility</li><li>Intravascular hemolysis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical findings</strong></p></td><td><ul><li>Onset within minutes to 24 hr of transfusion</li><li>Fever, chills, hypotension</li><li>Hemoglobinuria, flank pain</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>Positive direct Coombs test</li><li>Hemolysis (eg, &uarr; LDH, &uarr; indirect bilirubin)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Acute kidney failure</li><li>Disseminated intravascular coagulation</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>LDH</strong> = lactate dehydrogenase.</p></td></tr></tbody></table></div><p>This patient with fever, flank pain, and dark red urine 10 minutes after transfusion is having an <strong>acute hemolytic transfusion reaction</strong> (AHTR), a rare but potentially fatal reaction due to transfusion of mismatched blood (eg, <strong>ABO incompatibility</strong>).&nbsp; The most common etiology is clerical error (eg, patient misidentification).</p><p>AHTR typically occurs <strong>within minutes to hours</strong> of transfusion due to host antibodies attacking donor blood antigens.&nbsp; The result is massive red blood cell destruction (ie, <strong>intravascular hemolysis</strong>), which leads to toxic hemoglobin buildup in the kidney, renal tubular cell injury, and subsequent <strong>acute renal failure</strong>.&nbsp; Therefore, findings that raise suspicion&nbsp;for AHTR include&nbsp;<strong>flank pain</strong> and&nbsp;dark red urine (ie, <strong>hemoglobinuria</strong>) as well as&nbsp;<strong>fever</strong>, tachycardia, and hypotension (due to inflammatory cytokine release) shortly following a transfusion.&nbsp; Patients may also have elevated lactate dehydrogenase levels (from hemolysis)&nbsp;and <strong>disseminated intravascular coagulation</strong> (eg,&nbsp;oozing intravenous site).</p><p>Diagnosis of AHTR is with a positive <strong>direct Coombs test</strong>,&nbsp;reflecting antibody-coated red blood cells.&nbsp; Management includes immediate cessation of transfusion, aggressive intravenous fluid administration, and supportive care.</p><p><strong>(Choice A)</strong>&nbsp; Blood culture and antibiotics are indicated for a transfusion-transmitted bacterial infection (TTBI) or for urinary tract infection (UTI), which can present with fever, tachycardia, and hypotension.&nbsp; However, TTBI typically develops over hours (not minutes), and flank pain and hemoglobinuria are usually not present.&nbsp; UTI can cause flank pain (eg, pyelonephritis) and hematuria, but AHTR is a much more likely explanation of this patient&#39;s sudden-onset hypotension and acute disseminated intravascular coagulation within minutes of a transfusion.</p><p><strong>(Choices B and E)</strong>&nbsp; Cystoscopy and renal ultrasound can identify a urinary tract obstruction or renal mass, which may present with flank pain and dark red urine.&nbsp; However, these conditions do not cause hypotension or acute disseminated intravascular coagulation.</p><p><strong>(Choice D)</strong>&nbsp; IgA levels are measured in patients with a suspected anaphylactic transfusion reaction, which typically presents within <a href=\"7207\">seconds to minutes</a> of transfusion initiation.&nbsp; Patients with this reaction have angioedema and respiratory distress, which are not seen in this patient.</p><p><strong>Educational objective:</strong><br>Acute hemolytic transfusion reaction is a rare but potentially fatal condition due to transfusion of mismatched blood (eg, ABO incompatibility).&nbsp; Patients can develop fever, hypotension, flank pain, hemoglobinuria, and disseminated intravascular coagulation within minutes to hours of transfusion.&nbsp; Diagnosis is with a positive direct Coombs test.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3303,
            "topic": "Blood transfusion",
            "titleId": 3303,
            "title": "Blood transfusion",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Blood culture",
                    "choiceNumber": 1,
                    "correctTaken": 1571,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cystoscopy",
                    "choiceNumber": 2,
                    "correctTaken": 822,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Direct Coombs test",
                    "choiceNumber": 3,
                    "correctTaken": 13821,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "IgA level",
                    "choiceNumber": 4,
                    "correctTaken": 3243,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Renal ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 1831,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "347,406,true,-1,1*1011,1078,true,-1,1*1193,1454,true,-1,1*1559,1680,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28778288",
                    "mediaDataId": 0,
                    "title": "Adverse reactions to transfusion of blood products and best practices for prevention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28778288",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31291517",
                    "mediaDataId": 0,
                    "title": "Hemolytic transfusion reactions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31291517",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 21288,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 821,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 18531,
            "questionIndex": 20002,
            "questionText": "<p>A 21-year-old man is brought to the emergency department after being stepped on by a bull approximately 30 minutes ago.&nbsp; The patient was bucked off of the bull, whose hind feet landed on his chest.&nbsp; On arrival, blood pressure is 75/50 mm Hg, pulse is 140/min, and respirations are 24/min.&nbsp; On examination, the patient moans in pain but does not answer questions.&nbsp; Two hoof prints are seen in the middle of the chest.&nbsp; He has decreased bilateral breath sounds, and crepitus is present over the anterior chest walls bilaterally.&nbsp; The abdomen is soft and nondistended.&nbsp; There is no obvious injury to the extremities, but they are cool, and capillary refill is decreased.&nbsp; Bilateral chest tubes are immediately placed, and 1.5 L of blood is returned from each side.&nbsp; Vital signs do not improve after placement of chest tubes.&nbsp; Four units of packed red blood cells are prepared for transfusion.&nbsp; What other blood products, if any, should also be administered at this time?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with a severe crush injury to the chest has signs of <strong>hemorrhagic shock</strong> (eg, hypotension, tachycardia, narrow pulse pressure, altered mental status, decreased capillary refill) from a noncompressible (intrathoracic) site (ie, bleeding source cannot be controlled by compression or tourniquet).&nbsp; Hemorrhagic shock is the leading cause of death in acute traumatic injuries, and this patient likely needs <strong>massive transfusions</strong> (eg, &gt;3 units in 30 min) until definitive hemorrhage control can be obtained in the operating room.</p><p><strong>Massive transfusion protocols</strong>, developed to standardize resuscitation, are likely required in patients with &#8805;2 of the following:</p><ul><li><p>Penetrating mechanism of injury</p></li><li><p>Positive focused assessment with sonography in trauma examination (ie, evidence of hemorrhage)</p></li><li><p>Systolic blood pressure &#8804;90 mm Hg</p></li><li><p>Pulse &#8805;120/min</p></li></ul><p>The appropriate <strong>proportions</strong> and types of blood products should be carefully considered to optimize volume status and tissue oxygenation and to reduce acid-base abnormalities and coagulopathy.&nbsp; Administering blood products in a <strong>1:1:1 ratio</strong> of fresh frozen plasma [FFP]/packed red blood cells/platelets mitigates <strong>coagulopathy</strong>.&nbsp; Trauma itself can lead to coagulopathy due to dysregulation and inflammation.&nbsp; Coagulopathy can occur due to acidosis (hypoperfusion), hypothermia (transfusion of cold intravenous solutions), hemodilution (eg, clotting factor dilution), and factor consumption.&nbsp; If available, whole blood (packed red blood cells + plasma) is an alternative to the 1:1:1 ratio.</p><p>Adjunct therapies for hemorrhagic shock include tranexamic acid (antifibrinolytic agent), which is effective in a subset of patients with acute life-threatening hemorrhage if administered within the first 3 hours of injury, and topical hemostatic agents (eg, kaolin-impregnated sponge, fibrin sealant dressing), which are applied to control external hemorrhage.</p><p><strong>(Choices A, C, D, and E)</strong>&nbsp; Administering more of one type of blood product dilutes the circulating amount of the others and increases coagulopathy risk.&nbsp; FFP (containing all clotting factors and plasma proteins) alone is usually considered for severe coagulopathy (eg, liver disease, disseminated intravascular coagulation) with active bleeding, some cases of warfarin-induced bleeding, or some inherited coagulopathies.&nbsp; Platelets are typically transfused for a platelet count &lt;10,000/mm<font size=\"2\"><sup>3</sup></font> (risk of spontaneous hemorrhage) or a platelet count &lt;50,000/mm<font size=\"2\"><sup>3</sup></font> with active bleeding.&nbsp; Cryoprecipitate is considered with low fibrinogen (eg, &lt;100 mg/dL).</p><p><strong>Educational objective:</strong><br>Blood products should be administered early in patients with signs of hemorrhagic shock.&nbsp; They should be administered in a ratio of 1:1:1 (fresh frozen plasma/packed red blood cells/platelets) to reduce coagulopathy, a leading contributor to mortality in trauma patients.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3303,
            "topic": "Blood transfusion",
            "titleId": 3303,
            "title": "Blood transfusion",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "2",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "4 units of cryoprecipitate only",
                    "choiceNumber": 1,
                    "correctTaken": 510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "4 units of fresh frozen plasma and 4 units of platelets",
                    "choiceNumber": 2,
                    "correctTaken": 10518,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "4 units of fresh frozen plasma only",
                    "choiceNumber": 3,
                    "correctTaken": 2450,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "4 units of platelets only",
                    "choiceNumber": 4,
                    "correctTaken": 610,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional blood products",
                    "choiceNumber": 5,
                    "correctTaken": 3384,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2497,2566,true,-1,1*336,354,true,-1,1*437,564,true,-1,1*565,873,true,-1,1*1278,1559,true,-1,1*1560,1921,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25535421",
                    "mediaDataId": 0,
                    "title": "Massive transfusion and massive transfusion protocols.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25535421",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 129,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 17472,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1037,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 4438,
            "questionIndex": 4438,
            "questionText": "<p>A 6-year-old boy is brought to the office by his mother due to bleeding gums for the past 3 months.&nbsp; The patient brushes his teeth regularly and visits a dentist twice per year; his most recent dentist appointment 6 months ago was normal.&nbsp; The patient has become easily fatigued over the last 3-4 weeks and is not as active as he was previously.&nbsp; Height is below the 5th percentile and weight is at the 25th percentile for age.&nbsp; Several small patches of hypopigmentation are noted on the trunk.&nbsp; The thumbs appear hypoplastic and thenar eminences are flattened.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Leukocytes</td><td>3,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Hemoglobin</td><td>6.5 g/dL</td></tr><tr><td>Mean corpuscular volume</td><td>112 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Platelets</td><td>40,000/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42302\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Fanconi anemia</strong></p></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Pathophysiology</strong></p></td><td style=\"width: 65%;\"><ul><li>Inherited DNA repair defect</li><li>Bone marrow failure</li></ul></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Clinical findings</strong></p></td><td style=\"width: 65%;\"><ul><li>Short stature</li><li>Hypo-/hyperpigmented macules</li><li>Abnormal thumbs</li><li>Genitourinary malformations</li></ul></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Laboratory findings</strong></p></td><td style=\"width: 65%;\"><ul><li>Pancytopenia</li><li>Positive chromosomal breakage testing</li></ul></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 65%;\"><ul><li>Hematopoietic stem cell transplant</li></ul></td></tr></tbody></table></div><p>This patient most likely has <strong>Fanconi anemia</strong> (FA), the most common <strong>congenital</strong> cause of aplastic anemia (ie, <strong>bone marrow failure</strong>, <strong>pancytopenia</strong>).&nbsp; FA is typically an autosomal recessive disorder caused by a <strong>DNA repair defect</strong>.&nbsp; Damaged, unstable DNA impairs normal hematopoietic stem cell production and can also lead to increased susceptibility to malignancy (eg, leukemia).</p><p>Patients usually present in childhood with signs of thrombocytopenia (eg, bleeding, bruising), as in this case, with progression to leukopenia (eg, infections) and anemia (eg, fatigue) over time.&nbsp; Anemia is usually macrocytic due to fetal erythropoiesis that occurs during periods of chronic hematopoietic stress.&nbsp; Additional characteristic features of FA include <strong>short stature</strong>, hyper- or <strong>hypopigmentation</strong>, and absent or <strong>hypoplastic thumbs</strong>, as seen in this patient.&nbsp; Additional abnormalities of the hand may include polydactyly or a flat thenar eminence.</p><p>Diagnosis of FA is made by demonstrating chromosomal breakage following DNA exposure to interstrand crosslinking agents.&nbsp; Definitive treatment is hematopoietic stem cell transplantation.</p><p><strong>(Choice A)</strong>&nbsp; Benzene, found in solvents, polishes, and gasoline, is an industrial chemical that can cause chromosomal breakage and aplastic anemia.&nbsp; However, this patient&#39;s thumb and skin findings are suggestive of FA.</p><p><strong>(Choice B)</strong>&nbsp; Cobalamin (vitamin B<font size=\"2\"><sub>12</sub></font>) deficiency presents with macrocytic anemia and is most commonly caused by pernicious anemia or inadequate dietary intake, which are both extremely rare in children.</p><p><strong>(Choice C)</strong>&nbsp; Congenital infections (eg, toxoplasmosis, rubella, cytomegalovirus) may cause dysmorphisms and perinatal morbidity (eg, growth restriction) and mortality but not chronic pancytopenia.</p><p><strong>(Choice E)</strong>&nbsp; Glucose-6-phosphate dehydrogenase deficiency is a red blood cell enzyme deficiency causing anemia.&nbsp; Oxidant stress (eg, sulfonamides, fava beans, infection) in affected patients can cause episodic hemolysis but not leukopenia or thrombocytopenia.</p><p><strong>(Choice F)</strong>&nbsp; A minority of patients with thymic tumors (eg, thymoma) have red cell aplasia, but lymphocyte and platelet counts are normal.&nbsp; Thymic tumors are rare in children.</p><p><strong>Educational objective:</strong><br>Fanconi anemia is the most common cause of congenital bone marrow failure and is due to defective DNA repair.&nbsp; In addition to pancytopenia, characteristic features include short stature, thumb anomalies, and abnormal skin pigmentation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3251,
            "topic": "Aplastic anemia",
            "titleId": 3251,
            "title": "Aplastic anemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Benzene exposure",
                    "choiceNumber": 1,
                    "correctTaken": 1559,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cobalamin deficiency",
                    "choiceNumber": 2,
                    "correctTaken": 2122,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital infection",
                    "choiceNumber": 3,
                    "correctTaken": 648,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "DNA repair defect",
                    "choiceNumber": 4,
                    "correctTaken": 10293,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Red blood cell enzyme deficiency",
                    "choiceNumber": 5,
                    "correctTaken": 1018,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thymic tumor",
                    "choiceNumber": 6,
                    "correctTaken": 707,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "61,88,true,-1,1*186,213,true,-1,1*234,284,true,-1,1*295,329,true,-1,1*646,701,true,-1,1*1257,1344,true,-1,1*1345,1442,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24773018",
                    "mediaDataId": 0,
                    "title": "The Fanconi anemia DNA repair pathway:  structural and functional insights into a complex disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24773018",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22160080",
                    "mediaDataId": 0,
                    "title": "Fanconi anemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22160080",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20301575",
                    "mediaDataId": 0,
                    "title": "Fanconi anemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20301575",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 113,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 16347,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 675,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 15428,
            "questionIndex": 16854,
            "questionText": "<p>A 62-year-old man comes to the office due to an abnormal chest x-ray.&nbsp; Two weeks ago, the patient was seen at an emergency department after a motor vehicle collision.&nbsp; Evaluation showed no significant trauma, but a chest x-ray revealed enlarged mediastinal lymph nodes.&nbsp; The patient has had no fever, cough, or dyspnea but has had nonpainful nodules in his axillae for the past several months.&nbsp; Medical history includes hypertension, for which he takes chlorthalidone.&nbsp; He is lifelong nonsmoker and drinks alcohol occasionally.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination reveals clear lungs and normal heart sounds.&nbsp; Bilateral axillary and inguinal lymph nodes are enlarged and nontender.&nbsp; There is no rash or extremity edema.&nbsp; Blood cell counts and serum chemistry studies are within normal limits.&nbsp; A chest x-ray from a year ago also shows mediastinal lymphadenopathy.&nbsp; Which of the following is the most likely underlying cause of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s long-standing lymphadenopathy raises suspicion for <strong>follicular lymphoma</strong>, a common form of non-Hodgkin lymphoma (NHL) that often presents in elderly patients.&nbsp; Most cases present in an <strong>indolent</strong> fashion with months or years of <strong>painless peripheral lymphadenopathy</strong> in the cervical, axillary, or inguinal region. &nbsp;&nbsp;Although hilar and mediastinal lymphadenopathy&nbsp;occurs, large mediastinal masses are rare. &nbsp;The lymphadenopathy can wax and wane. &nbsp;B symptoms (eg, night sweats, fever, weight loss) and laboratory abnormalities (eg, elevated lactate dehydrogenase, cytopenia) are generally absent.</p><p>Follicular lymphoma is usually diagnosed with excisional lymph node biopsy.&nbsp; Histopathology typically shows nodular growth of follicular lymphocytes, and immunophenotyping most often reveals (in ~85% of cases) a translocation between chromosomes 14 and 18 that leads to the <strong>overexpression of</strong>&nbsp;<em><strong>BCL-2</strong></em>, an oncogene that prevents apoptosis.</p><p><strong>(Choice A)</strong>&nbsp; Antinuclear antibody is a diagnostic marker for systemic lupus erythematosus (SLE).&nbsp; Although patients with uncontrolled SLE sometimes have peripheral lymphadenopathy, other diagnostic manifestations (eg, arthralgia, rash, serositis, cytopenia) are usually present.</p><p><strong>(Choice C)</strong>&nbsp; Disseminated histoplasmosis can cause peripheral lymphadenopathy, but almost all cases are accompanied by fever, fatigue, weight loss, and laboratory abnormalities (eg, transaminase elevation, anemia of chronic disease).</p><p><strong>(Choice D)</strong>&nbsp; Certain drugs (eg, phenytoin) can cause painless peripheral lymphadenopathy without other symptoms.&nbsp; However, chlorthalidone is not a common culprit.</p><p><strong>(Choice E)</strong>&nbsp; Lung cancer can cause hilar and mediastinal lymphadenopathy, but chest x-ray would likely show a pulmonary mass.&nbsp; In addition, progressive symptoms (eg, worsened chest x-ray, weight loss, pulmonary manifestations) would be expected over the course of a year.&nbsp; Furthermore, spread to the inguinal lymph nodes would be atypical.</p><p><strong>Educational objective:</strong><br>Follicular lymphoma is a common form of non-Hodgkin lymphoma.&nbsp; It generally presents in an older patient with months or years of waxing and waning lymphadenopathy.&nbsp; B symptoms and laboratory abnormalities are rare, but mediastinal/hilar lymphadenopathy is sometimes seen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 7942,
            "topic": "Nonhodgkin lymphoma",
            "titleId": 7942,
            "title": "Nonhodgkin lymphoma",
            "topicAttributeId": 330684,
            "topicAttribute": "White blood cell disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody formation",
                    "choiceNumber": 1,
                    "correctTaken": 2123,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>BCL-2</em> gene overexpression",
                    "choiceNumber": 2,
                    "correctTaken": 12199,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Disseminated fungal infection",
                    "choiceNumber": 3,
                    "correctTaken": 886,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Drug hypersensitivity reaction",
                    "choiceNumber": 4,
                    "correctTaken": 1035,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metastasis of a lung neoplasm",
                    "choiceNumber": 5,
                    "correctTaken": 1812,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "842,968,true,-1,1*1258,1479,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 56,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 18055,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 770,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 4847,
            "questionIndex": 4847,
            "questionText": "<p>An 18-month-old boy is brought to the emergency department due to blood in his stool, which the parents noticed when changing his diaper.&nbsp; The infant has had no previous bleeding and has been eating and drinking normally.&nbsp; He has a history of recurrent otitis media, frequent herpes labialis, and 2 episodes of pneumonia.&nbsp; Vital signs are normal.&nbsp; On examination, the patient is well developed, well nourished, and has a fair complexion.&nbsp; He has eczema on his cheeks, trunk, and extremities.&nbsp; Scattered petechiae are also visible on his lower extremities.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Laboratory studies show a platelet count of 24,000/mm<font size=\"2\"><sup>3</sup></font> and a leukocyte count of 9,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Peripheral smear confirms the low platelet count and that the platelets are small.&nbsp; Genetic testing confirms the diagnosis.&nbsp; Which of the following processes is most likely affected by this patient&#39;s gene mutation?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t41116\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Wiskott-Aldrich syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>X-linked recessive defect in <em>WAS</em> protein gene</li><li>Impaired cytoskeleton changes in leukocytes, platelets</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Eczema</li><li>Microthrombocytopenia (small platelets, low platelet count)</li><li>Recurrent infections</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Stem cell transplant</li></ul></td></tr></tbody></table></div></p><p>This patient&#39;s <strong>eczema</strong> (itchy, red, scaly skin), <strong>microthrombocytopenia</strong> (small and low number of platelets), and <strong>recurrent infections</strong> are consistent with <strong>Wiskott-Aldrich syndrome</strong> (WAS).&nbsp; WAS is caused by an <strong>X-linked recessive</strong> defect in the <em>WAS</em> gene.&nbsp; This gene is primarily expressed in hematopoietic cells and regulates <strong>cytoskeleton</strong> remodeling in response to cell signaling.&nbsp; In WAS, the actin cytoskeleton in white blood cells is abnormal, resulting in immune dysfunction due to impaired cellular migration and immune synapse formation.&nbsp; Patients are at increased risk for recurrent bacterial, viral, and fungal infections.</p><p>Similarly, the cytoskeleton of platelets is also dysfunctional.&nbsp; Virtually all patients have significantly decreased platelet counts and size at the time of diagnosis.&nbsp; The resulting clinical findings can range from petechiae or purpura to severe bleeding such as intracranial hemorrhage, hematemesis, or hematochezia.&nbsp; In addition, autoimmune disorders (eg, eczema) occur in most patients with WAS.&nbsp; The treatment of WAS is <strong>hematopoietic stem cell transplantation</strong>.</p><p><strong>(Choice A)</strong>&nbsp; T cell lymphocytes that lack CD40 ligand cannot bind to the CD40 receptor on B cells.&nbsp; Without CD40 activation, B cells cannot switch the antibody isotype they produce (eg, from IgM to IgG or IgA), resulting in hyper-IgM syndrome.</p><p><strong>(Choice C)</strong>&nbsp; Ataxia telangiectasia is a T cell deficiency associated with a defect in DNA repair.&nbsp; In addition to immune dysfunction, patients with ataxia telangiectasia experience progressive cerebellar degeneration and are at high risk for cancer.</p><p><strong>(Choice D)</strong>&nbsp; Chronic granulomatous disease results from an inability of phagocytes to produce hydrogen peroxide in their lysosomes.&nbsp; Abscesses due to fungi or catalase-positive bacteria (eg, <em>Staphylococcus aureus</em>) are the characteristic feature.</p><p><strong>(Choice E)</strong>&nbsp; Severe combined immunodeficiency (SCID) results from a severe T cell deficiency.&nbsp; A variety of gene defects can cause SCID and all prevent interleukin-7-driven maturation of T cells in the thymus.&nbsp; Patients with SCID have virtually no functional T cells; lack of T cells causes severe B cell dysfunction as well.</p><p><strong>Educational objective:</strong><br>Wiskott-Aldrich syndrome is an X-linked disorder characterized by the triad of thrombocytopenia, eczema, and recurrent infections.&nbsp; The thrombocytopenia is the most consistent feature and is characterized by a significant reduction in platelet volume and size.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 19960,
            "topic": "Wiskott-aldrich syndrome",
            "titleId": 19960,
            "title": "Wiskott-aldrich syndrome",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antibody class switching",
                    "choiceNumber": 1,
                    "correctTaken": 2406,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cytoskeleton regulation",
                    "choiceNumber": 2,
                    "correctTaken": 7826,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "DNA repair",
                    "choiceNumber": 3,
                    "correctTaken": 2946,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydrogen peroxide production",
                    "choiceNumber": 4,
                    "correctTaken": 841,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maturation of T cells",
                    "choiceNumber": 5,
                    "correctTaken": 2362,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "111,165,true,-1,1*1035,1246,true,-1,1*2260,2340,true,-1,1*2396,2455,true,-1,1*1784,1885,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24817816",
                    "mediaDataId": 0,
                    "title": "Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24817816",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26331277",
                    "mediaDataId": 0,
                    "title": "WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26331277",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 51,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16381,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 899,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 2887,
            "questionIndex": 2887,
            "questionText": "<p>A 65-year-old man is brought to the emergency department due to high fevers and confusion.&nbsp; He has had 2 days of cough productive of greenish sputum.&nbsp; He has a history of well-controlled type 2 diabetes mellitus and was treated for bronchitis twice in the last 4 months.&nbsp; The patient received the influenza vaccine this year.&nbsp; He has smoked a pack of cigarettes daily for the past 27 years and drinks alcohol occasionally.&nbsp; Temperature is 38.4 C (101.2 F), blood pressure is 118/74 mm Hg, pulse is 98/min, and respirations are 24/min.&nbsp; His pulse oximetry reading is 92% on room air.&nbsp; The patient is obese.&nbsp; His anterior cervical lymph nodes are enlarged and nonpainful.&nbsp; His lungs are clear to auscultation except for scattered rales at the right lung base.&nbsp; Abdominal examination reveals a palpable liver edge and spleen tip.&nbsp; Chest-x ray shows a developing right lower lobe infiltrate.&nbsp; Laboratory studies are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"300\"><tbody><tr><td>Hematocrit</td><td>32%</td></tr><tr><td>Platelets</td><td>120,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Leukocytes</td><td>42,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Neutrophils</td><td>10%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bands</td><td>4%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Lymphocytes</td><td>85%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Monocytes</td><td>1%</td></tr></tbody></table></blockquote><p>Blood cultures are sent to the laboratory; antibiotics and supportive care are initiated.&nbsp; What is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t81531\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Chronic lymphocytic leukemia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Lymphadenopathy (cervical, supraclavicular, axillary)</li><li>Hepatosplenomegaly</li><li>Mild thrombocytopenia &amp; anemia</li><li>Often asymptomatic</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Severe lymphocytosis &amp; smudge cells</li><li>Flow cytometry</li><li>Lymph node &amp; bone marrow biopsy not generally needed</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prognosis</strong></p></td><td><ul><li>Median survival 10 years</li><li>Worse prognosis with:<ul style=\"list-style-type:circle;\"><li>Multiple chain lymphadenopathy</li><li>Hepatosplenomegaly</li><li>Anemia &amp; thrombocytopenia</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Infection</li><li>Autoimmune hemolytic anemia</li><li>Secondary malignancies (eg, Richter syndrome)</li></ul></td></tr></tbody></table><br /><br />&nbsp;</div></p><p>This patient with a fever, productive cough, and right lower lobe infiltrate likely has bacterial pneumonia.&nbsp; Most bacterial infections cause a mild to moderate leukocytosis with a predominance of neutrophils.&nbsp; This patient&#39;s complete blood count demonstrates a <strong>dramatic leukocytosis</strong>, primarily with <strong>lymphocytes</strong>.&nbsp; In an elderly patient, severe lymphocytosis combined with hepatosplenomegaly, lymphadenopathy, and bicytopenia (anemia, thrombocytopenia) strongly suggests underlying <strong>chronic lymphocytic leukemia</strong> (CLL).&nbsp; Although patients with CLL have high white blood cell counts, their immune systems are abnormal; hypogammaglobulinemia and defects in cell signaling increase the risk and severity of <strong>infections</strong> (a major complication of CLL).</p><p>CLL is diagnosed by <strong>flow cytometry</strong> (showing a clonality of mature B cells).</p><p><strong>(Choice A)</strong>&nbsp; Bronchoscopy with biopsy is sometimes used to determine the pathology of a lung mass, but it does not play a role in the diagnosis of CLL.&nbsp; This patient&#39;s lung infiltrate is likely pneumonia; bronchoscopy is not indicated at this time.</p><p><strong>(Choice B)</strong>&nbsp; Epstein-Barr virus serology can be used to diagnose infectious mononucleosis (IM).&nbsp; IM typically affects young adults and presents with fever, lymphadenopathy, malaise, and pharyngitis.&nbsp; Although splenomegaly, lymphadenopathy, and lymphocytosis can occur with IM, leukocytosis is generally mild (12,000-18,000/mm<font size=\"2\"><sup>3</sup></font>) and cytopenias are rare.</p><p><strong>(Choice D)</strong>&nbsp; The <em>JAK2</em> mutation is associated with myeloproliferative diseases, particularly polycythemia vera (PV).&nbsp; PV can lead to splenomegaly but usually causes an elevated hematocrit (&gt;50%), thrombocytosis, and thrombotic complications.</p><p><strong>(Choice E)</strong>&nbsp; Lymph node (LN) biopsy is not generally needed to diagnose CLL.&nbsp; Flow cytometry is the test of choice.&nbsp; LN biopsy is useful in diagnosing some lymphomas (eg, Hodgkin lymphoma, non-Hodgkin lymphoma).</p><p><strong>(Choice F)</strong>&nbsp; Serum protein electrophoresis can detect elevated levels of monoclonal proteins.&nbsp; It is typically used to diagnose multiple myeloma (MM).&nbsp; MM often presents with anemia and bone pain; peripheral smear shows rouleaux formation (red blood cells that appear stacked) and leukopenia.&nbsp; This patient has dramatic leukocytosis.</p><p><strong>Educational objective:</strong><br>Infections are a common complication of chronic lymphocytic leukemia (CLL).&nbsp; CLL is diagnosed by flow cytometry (clonality of mature B cells).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 14591,
            "topic": "Chronic lymphocytic leukemia",
            "titleId": 14591,
            "title": "Chronic lymphocytic leukemia",
            "topicAttributeId": 330684,
            "topicAttribute": "White blood cell disorders",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bronchoscopy",
                    "choiceNumber": 1,
                    "correctTaken": 2395,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epstein-Barr virus serology",
                    "choiceNumber": 2,
                    "correctTaken": 3084,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Flow cytometry of the peripheral blood",
                    "choiceNumber": 3,
                    "correctTaken": 8802,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>JAK2</em> mutation testing",
                    "choiceNumber": 4,
                    "correctTaken": 968,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lymph node biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 8805,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum protein electrophoresis",
                    "choiceNumber": 6,
                    "correctTaken": 882,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "247,261,true,-1,1*262,314,true,-1,1*350,447,true,-1,1*500,544,true,-1,1*2219,2418,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 85,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 24936,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 35,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 664,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 2641,
            "questionIndex": 2641,
            "questionText": "<p>A 16-year-old boy is brought to the emergency department due to a week of fever, dry cough, and weakness.&nbsp; Examination shows diffuse lymph node enlargement, mild hepatosplenomegaly, and scattered petechiae on the extremities.&nbsp; The testicles are normal and no neurologic abnormalities are present.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">8.9 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">44,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">102,800/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td style=\"vertical-align:middle;\">12 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Blood, plasma, and serum</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Lactate dehydrogenase</td><td style=\"vertical-align:middle;\">4,200 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Uric acid</td><td style=\"vertical-align:middle;\">8.2 mg/dL</td></tr></tbody></table><p>Peripheral blood smear reveals extensive blasts, and subsequent flow cytometry reveals T cell markers.&nbsp; A diagnosis of acute lymphoblastic leukemia is made.&nbsp; The patient is initiated on intravenous fluids, allopurinol, and combination chemotherapy.&nbsp; The following day, he develops nausea.&nbsp; Cardiac monitoring shows frequent premature ventricular beats.&nbsp; Repeat laboratory evaluation reveals leukocytes are 52,000/mm<font size=\"2\"><sup>3</sup></font>, blood urea nitrogen is 34 mg/dL, serum creatinine is 2.1 mg/dL, and lactate dehydrogenase level is 12,000 U/L.&nbsp; Which of the following additional results are expected in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31451\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Tumor lysis syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk</strong></p></td><td><ul><li>Tumors with high cell burden or rapid turnover</li><li>Combination chemotherapy/immunotherapy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Severe electrolyte abnormalities<ul style=\"list-style-type:circle;\"><li>&uarr; Phosphorus, potassium, uric acid</li><li>&darr; Calcium</li></ul></li><li>Acute kidney injury</li><li>Cardiac arrhythmias</li><li>Seizures</li></ul></td></tr><tr><td><p align=\"center\"><strong>Prophylaxis</strong></p></td><td><ul><li>Intravenous fluids</li><li>Xanthine oxidase inhibitor* or rasburicase</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Intravenous fluids + rasburicase</li><li>Continuous telemetry</li><li>Aggressive electrolyte monitoring &amp; treatment</li></ul></td></tr><tr><td colspan=\"2\"><p>*Allopurinol or febuxostat.</p></td></tr></tbody></table></div><p><strong>Tumor lysis syndrome</strong> (TLS) is common in patients with aggressive <strong>hematologic malignancies</strong> who are initiated on cytotoxic chemotherapy or immunotherapy.&nbsp; Large tumor burden (eg, some leukemias with elevated leukocyte count or lactate dehydrogenase levels) is a risk factor.&nbsp; Large-scale tumor cell death causes the massive release of <strong>intracellular products</strong> into the circulation, which results in potentially life-threatening electrolyte and metabolic abnormalities, including the following:</p><ul><li><strong>Hyperphosphatemia:</strong> Tumor cells have up to 3 times more intracellular phosphate than normal cells.&nbsp; Therefore, massive tumor cell lysis is often associated with hyperphosphatemia.&nbsp; This results in <strong>systemic hypocalcemia</strong> due to increased calcium-phosphate precipitation, including in the renal tubules, leading to obstructing <strong>calcium-phosphate stones</strong> that can cause acute kidney injury.</li></ul><ul><li><strong>Hyperkalemia:</strong> Because potassium is primarily sequestered in the intracellular space, massive tumor cell lysis can cause hyperkalemia, which increases risk of <strong>cardiac arrhythmia</strong>.</li></ul><ul><li><strong>Hyperuricemia:</strong> Purine nucleic acids released from lysed tumor cells are metabolized by xanthine oxidase into <strong>uric acid</strong>.&nbsp; Because uric acid is poorly soluble in the acidic environment of the renal distal tubules and collecting system, it precipitates into obstructing <strong>uric acid stones</strong>, which are another cause of <strong>acute kidney injury</strong>.&nbsp;</li></ul><p>Most symptoms of TLS (eg, nausea, vomiting, diarrhea, muscle cramps, seizures, tetany) are also caused by electrolyte abnormalities.&nbsp; TLS prophylaxis typically includes <strong>intravenous fluids</strong> to flush phosphorus, calcium, and uric acid out of the kidneys and the administration of an agent (eg, <strong>allopurinol</strong>, rasburicase, febuxostat) to reduce uric acid levels.</p><p><strong>Educational objective:</strong><br>Patients with aggressive hematologic malignancies are at risk of tumor lysis syndrome when initiated on cytotoxic chemotherapy or immunotherapy.&nbsp; Intracellular contents are released into the serum, leading to hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia (due to calcium phosphate binding in the renal tubules).&nbsp; Major complications include acute renal injury (uric acid/calcium phosphate tubular injury) and cardiac arrhythmia.&nbsp; Prophylaxis with intravenous fluids and uric acid inhibitors reduces the risk of kidney injury.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 19803,
            "topic": "Tumor lysis syndrome",
            "titleId": 19803,
            "title": "Tumor lysis syndrome",
            "topicAttributeId": 330801,
            "topicAttribute": "Principles of oncology",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table 390px=\"\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:390px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Decreased</td><td style=\"width:33%; vertical-align:middle;\">Decreased</td><td style=\"width:33%; vertical-align:middle;\">Decreased</td></tr></tbody></table>",
                    "choiceNumber": 1,
                    "correctTaken": 362,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table 390px=\"\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:390px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Decreased</td><td style=\"width:33%; vertical-align:middle;\">Decreased</td><td style=\"width:33%; vertical-align:middle;\">Increased</td></tr></tbody></table>",
                    "choiceNumber": 2,
                    "correctTaken": 1262,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table 390px=\"\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:390px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Decreased</td><td style=\"width:33%; vertical-align:middle;\">Increased</td><td style=\"width:33%; vertical-align:middle;\">Decreased</td></tr></tbody></table>",
                    "choiceNumber": 3,
                    "correctTaken": 1118,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table 390px=\"\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:390px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Decreased</td><td style=\"width:33%; vertical-align:middle;\">Increased</td><td style=\"width:33%; vertical-align:middle;\">Increased</td></tr></tbody></table>",
                    "choiceNumber": 4,
                    "correctTaken": 9938,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table 390px=\"\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:390px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Increased</td><td style=\"width:33%; vertical-align:middle;\">Increased</td><td style=\"width:33%; vertical-align:middle;\">Increased</td></tr></tbody></table>",
                    "choiceNumber": 5,
                    "correctTaken": 3067,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "648,769,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 15747,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table 390px=\"\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:390px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\"><strong>Calcium</strong></td><td style=\"width:33%; vertical-align:middle;\"><strong>Phosphate</strong></td><td style=\"width:33%; vertical-align:middle;\"><strong>Potassium</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 463,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 4861,
            "questionIndex": 4861,
            "questionText": "<p>A 5-year-old boy is brought to the emergency department by his mother&#39;s boyfriend for evaluation of thigh pain.&nbsp; This morning, the patient bumped into the edge of a table in the living room and now has swelling and pain in the right thigh.&nbsp; Family history is significant for a maternal uncle who died after developing intracranial hemorrhages from a minor head injury last year.&nbsp; Examination shows an uncomfortable-appearing boy with marked ecchymoses and swelling over the right quadriceps.&nbsp; Which of the following will most likely be found on further history and examination of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41222\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hemophilia A &amp; B</strong></p></td></tr><tr><td><p align=\"center\"><strong>Inheritance</strong></p></td><td><ul><li>X-linked recessive</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Delayed/prolonged bleeding after mild trauma<ul style=\"list-style-type:circle;\"><li>Hemarthrosis, intramuscular hematomas</li><li>Gastrointestinal or genitourinary tract bleeding</li><li>Intracranial hemorrhage</li></ul></li><li>Complications: hemophilic arthropathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>&uarr; Activated PTT</li><li>Normal platelet count &amp; PT</li><li>Absent or &darr; factor VIII (hemophilia A) or factor IX<br />(hemophilia B) activity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Factor replacement</li><li>Desmopressin for mild hemophilia A</li></ul></td></tr></tbody></table></div><p>This patient&#39;s thigh <strong>hematoma</strong> after minor trauma and family history of a bleeding disorder in a maternal uncle are concerning for <strong>hemophilia</strong>.&nbsp; Hemophilia is an <strong>X-linked recessive</strong> bleeding disorder due to deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B).&nbsp; The most common sites of bleeding are the joints (80%), especially the knee.&nbsp; <strong>Hemarthrosis</strong> presents with <strong>joint pain and swelling</strong> after minimal or no trauma, and episodes typically begin during toddlerhood when the child is ambulatory.&nbsp; Hemorrhage into the skeletal muscle (ie, hematoma) after minor trauma is also common.</p><p>Characteristic laboratory findings include a <strong>prolonged PTT</strong> and <strong>decreased or absent factor VIII or IX activity</strong>.&nbsp; Treatment involves replacing the missing factor with a recombinant or purified product.</p><p><strong>(Choice B)</strong>&nbsp; Posterior rib fractures are a red flag for child abuse.&nbsp; However, bruising on an extremity, as seen in this child, is often unintentional. &nbsp;Suspicious bruises include those that are patterned (eg, belt buckle, hand) or located on the neck, ear, torso, and buttocks.</p><p><strong>(Choice C)</strong>&nbsp; Petechiae (pinpoint red spots) are a result of broken capillaries and are associated with platelet disorders.&nbsp; Platelet disorders can present with mucosal bleeding but do not typically cause bleeding into muscle.</p><p><strong>(Choice D)</strong>&nbsp; Red papules on the trunk and lips represent cutaneous arteriovenous malformations.&nbsp; They can be seen in hereditary telangiectasia, an autosomal dominant disorder characterized by recurrent epistaxis and telangiectasias.&nbsp; Patients with hereditary telangiectasia are not predisposed to skeletal muscle hematomas.</p><p><strong>(Choice E)</strong>&nbsp; Heavy menstrual bleeding is common in women with von Willebrand disease.&nbsp; Abnormalities in platelet plug formation lead to prolonged mucosal bleeding (eg, oropharyngeal, gastrointestinal, uterine), but bleeding into deep tissue is not seen.</p><p><strong>Educational objective:</strong><br>Hemophilia is an X-linked recessive bleeding disorder that can present with recurrent hemarthrosis and skeletal muscle hematoma after minor trauma.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 16524,
            "topic": "Hemophilias",
            "titleId": 16524,
            "title": "Hemophilias",
            "topicAttributeId": 330607,
            "topicAttribute": "Hemostasis and thrombosis",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Episodes of joint pain with swelling",
                    "choiceNumber": 1,
                    "correctTaken": 9884,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Old, healed rib fractures",
                    "choiceNumber": 2,
                    "correctTaken": 2205,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pinpoint red spots on extremities",
                    "choiceNumber": 3,
                    "correctTaken": 1639,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Red papules on the trunk and lips",
                    "choiceNumber": 4,
                    "correctTaken": 528,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sister with heavy menstrual bleeding",
                    "choiceNumber": 5,
                    "correctTaken": 3100,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2128,2199,true,-1,1*1090,1289,true,-1,1*228,289,true,-1,1*458,492,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23818083",
                    "mediaDataId": 0,
                    "title": "Hemophilia: in review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23818083",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 106,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 17359,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 553,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 14272,
            "questionIndex": 15680,
            "questionText": "<p>A 12-year-old girl recently diagnosed with idiopathic aplastic anemia is brought to the clinic for follow-up.&nbsp; Since her visit a week ago, the patient has developed red spots and bruising on her arms and legs.&nbsp; Laboratory evaluation reveals an absolute neutrophil count of 420 cells/mm<font size=\"2\"><sup>3</sup></font> and platelet count of 7,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; She is given a platelet transfusion.&nbsp; Toward the end of the transfusion, the patient develops a rash on her chest that spreads to the rest of the body.&nbsp; Temperature is 37.2 C (99.0 F), blood pressure is 110/82 mm Hg, pulse is 90/min, and respirations are 18/min.&nbsp; Pulse oximetry is 98% on room air.&nbsp; Oropharynx examination is normal.&nbsp; Lung examination is unremarkable.&nbsp; Skin examination reveals a diffuse, urticarial rash along the trunk and extremities, along with pinpoint, nonblanching, red macules and bruises at the extremities.&nbsp; The transfusion is stopped, and the patient receives diphenhydramine.&nbsp; Vital signs remain stable over the next hour, and the rash improves slightly.&nbsp; Which of the following is the best next step in evaluation of this patient&#39;s transfusion reaction?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t54798\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Transfusion reactions</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Anaphylactic</strong></p></td><td><p align=\"center\"><strong>Urticarial</strong></p></td></tr><tr><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><ul><li>Anti-IgA antibodies (IgG or IgE) in IgA-deficient patient against donor blood IgA</li></ul></td><td><ul><li>Preformed recipient IgE antibodies against soluble allergen in donated plasma</li></ul></td></tr><tr><td><p align=\"center\"><strong>Onset</strong></p></td><td><ul><li>Seconds to minutes</li></ul></td><td><ul><li>Hours</li></ul></td></tr><tr><td><p align=\"center\"><strong>Findings</strong></p></td><td><ul><li>Respiratory distress/wheeze</li><li>Angioedema</li><li>Hypotension</li><li>Hives</li></ul></td><td><ul><li>Hives</li><li>Itching</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Immediate cessation of transfusion</li><li>Epinephrine</li><li>Antihistamines, oxygen, fluids &amp; vasopressors</li></ul></td><td><ul><li>Immediate cessation of transfusion</li><li>Antihistamines</li><li>Resume transfusion if patient is otherwise asymptomatic</li></ul></td></tr></tbody></table></div><p>This hemodynamically stable patient developed isolated urticaria during a transfusion, which is consistent with an <strong>urticarial transfusion reaction</strong>.&nbsp; Urticarial transfusion reactions are <strong>common</strong> and typically mild.&nbsp; Pathogenesis involves histamine release due to <strong>preformed recipient IgE antibodies</strong> reacting against a soluble allergen in the donated plasma, or vice versa (ie, donor IgE against recipient allergen).</p><p>Symptoms are limited to <strong>hives</strong> and/or <strong>itching</strong> and develop hours after transfusion initiation.&nbsp; In contrast, hives due to anaphylaxis typically occur within minutes of transfusion initiation and develop in conjunction with wheezing, angioedema, and/or hypotension.</p><p>Management of an urticarial transfusion reaction includes immediate <strong>cessation</strong> of the <strong>transfusion</strong> and administration of <strong>diphenhydramine</strong> (ie, antihistamine) if urticaria is extensive.&nbsp; Diagnosis is confirmed if symptoms improve and no signs of anaphylaxis develop.&nbsp; The <strong>transfusion</strong> can then be <strong>resumed without additional evaluation</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Transfusion-transmitted bacterial infection (TTBI) is an uncommon, severe complication of transfusion that presents with fever, chills, and hypotension from a contaminated blood product (most commonly platelets).&nbsp; Cultures should be obtained from the recipient as well as from the transfused product to identify the pathogen and potential source of infection, respectively.&nbsp; This patient has no symptoms of TTBI, and therefore testing is not warranted.</p><p><strong>(Choices B, D, and E)</strong>&nbsp; Acute hemolytic transfusion reaction is a rare but potentially fatal reaction caused by mismatched donor and recipient blood (ie, ABO incompatibility) due to clerical error.&nbsp; Classic symptoms include fever, flank pain, hypotension, and dark/pink urine (ie, hemoglobinuria), none of which are seen in this patient.&nbsp; Evaluation typically reveals positive direct antibody (Coombs) testing.&nbsp; In cases complicated by disseminated intravascular coagulation, schistocytes on peripheral blood smear and prolonged PT and PTT are also seen.&nbsp; This patient&#39;s petechiae (pinpoint, nonblanching macules) and ecchymoses are consistent with her established thrombocytopenia and were present prior to transfusion.</p><p><strong>Educational objective:</strong><br>Urticarial transfusion reactions are common and caused by preformed recipient IgE antibodies reacting against a soluble allergen in the donated plasma (or vice versa).&nbsp; Patients have isolated urticaria that improves with transfusion cessation and diphenhydramine administration.&nbsp; If no signs of anaphylaxis are present (eg, wheeze, angioedema, hypotension), the transfusion can be resumed without additional evaluation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3303,
            "topic": "Blood transfusion",
            "titleId": 3303,
            "title": "Blood transfusion",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Culture of the transfused product",
                    "choiceNumber": 1,
                    "correctTaken": 325,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Direct antibody (Coombs) test",
                    "choiceNumber": 2,
                    "correctTaken": 5385,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional evaluation indicated",
                    "choiceNumber": 3,
                    "correctTaken": 9412,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peripheral blood smear",
                    "choiceNumber": 4,
                    "correctTaken": 578,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "PT and PTT levels",
                    "choiceNumber": 5,
                    "correctTaken": 680,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "980,1242,true,-1,1*1243,1573,true,-1,1*1799,1958,true,-1,1*87,277,true,-1,1*369,566,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29489247",
                    "mediaDataId": 0,
                    "title": "Transfusion reactions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29489247",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16380,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 817,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 4671,
            "questionIndex": 4671,
            "questionText": "<p>A 16-year-old boy comes to the emergency department due to a dirt bike collision.&nbsp; Trauma evaluation reveals a femur fracture, and the patient undergoes open reduction and internal fixation.&nbsp; He receives a packed red blood cell transfusion postoperatively.&nbsp; Five minutes after the transfusion begins, the patient acutely develops chills and severe flank pain.&nbsp; Temperature is 39.1 C (102.4 F), blood pressure is 88/40 mm Hg, pulse is 130/min, and respirations are 30/min.&nbsp; Physical examination shows bleeding around the intravenous catheter site.&nbsp; Breath sounds are normal.&nbsp; Which of the following is the most likely cause of this patient&#39;s transfusion reaction?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t54680\"><table class=\"table-default-style\" style=\"width:88.96%\"><tbody><tr><td colspan=\"4\" style=\"width:100.0%\"><p align=\"center\"><strong>Immunologic blood transfusion reactions</strong></p></td></tr><tr><td style=\"width:24.16%\"><p align=\"center\"><strong>Transfusion reaction</strong></p></td><td style=\"width:18.48%\"><p align=\"center\"><strong>Onset*</strong></p></td><td style=\"width:23.56%\"><p align=\"center\"><strong>Cause</strong></p></td><td style=\"width:33.8%\"><p align=\"center\"><strong>Key features</strong></p></td></tr><tr><td style=\"width:24.16%\"><p align=\"center\"><strong>Anaphylactic</strong></p></td><td style=\"width:18.48%\"><p align=\"center\">Within seconds to minutes</p></td><td style=\"width:23.56%\"><p align=\"center\">Recipient anti-IgA antibodies directed against donor blood IgA</p></td><td style=\"width:33.8%\"><ul><li>Angioedema, hypotension, respiratory distress/wheezing,<br>shock<a name=\"_Hlk22717699\"></a></li><li>IgA-deficient recipient</li></ul></td></tr><tr><td style=\"width:24.16%\"><p align=\"center\"><strong>Acute hemolytic</strong></p></td><td style=\"width:18.48%\"><p align=\"center\">Within<br>1 hr</p></td><td style=\"width:23.56%\"><p align=\"center\">ABO incompatibility (often clerical error)</p></td><td style=\"width:33.8%\"><ul><li>Fever, flank pain, hemoglobinuria</li><li>Disseminated intravascular coagulation</li><li>Positive Coombs test</li></ul></td></tr><tr><td style=\"width:24.16%\"><p align=\"center\"><strong>Febrile nonhemolytic </strong>(most common reaction)</p></td><td style=\"width:18.48%\"><p align=\"center\">Within<br>1-6 hr</p></td><td style=\"width:23.56%\"><p align=\"center\">Cytokine accumulation during blood storage</p></td><td style=\"width:33.8%\"><ul><li>Fever &amp; chills</li></ul></td></tr><tr><td style=\"width:24.16%\"><p align=\"center\"><strong>Urticarial</strong></p></td><td style=\"width:18.48%\"><p align=\"center\">Within<br>2-3 hr</p></td><td style=\"width:23.56%\"><p align=\"center\">Recipient IgE against blood product component</p></td><td style=\"width:33.8%\"><ul><li>Urticaria</li></ul></td></tr><tr><td style=\"width:24.16%\"><p align=\"center\"><strong>Transfusion-related acute lung injury</strong></p></td><td style=\"width:18.48%\"><p align=\"center\">Within<br>6 hr</p></td><td style=\"width:23.56%\"><p align=\"center\">Donor anti-leukocyte antibodies</p></td><td style=\"width:33.8%\"><ul><li>Respiratory distress</li><li>Noncardiogenic pulmonary edema with bilateral pulmonary infiltrates</li></ul></td></tr><tr><td style=\"width:24.16%\"><p align=\"center\"><strong>Delayed hemolytic</strong></p></td><td style=\"width:18.48%\"><p align=\"center\">Within days to weeks</p></td><td style=\"width:23.56%\"><p align=\"center\">Anamnestic antibody response</p></td><td style=\"width:33.8%\"><ul><li>Often asymptomatic</li><li>Laboratory evidence of hemolytic anemia</li><li>Positive Coombs test, positive new antibody screen</li></ul></td></tr><tr><td style=\"width:24.16%\"><p align=\"center\"><strong>Graft versus host</strong></p></td><td style=\"width:18.48%\"><p align=\"center\">Within weeks</p></td><td style=\"width:23.56%\"><p align=\"center\">Donor T lymphocytes</p></td><td style=\"width:33.8%\"><ul><li>Rash, fever, gastrointestinal symptoms, pancytopenia</li></ul></td></tr><tr><td colspan=\"4\" style=\"width:100.0%\"><p>*Time after transfusion initiation.</p></td></tr></tbody></table></div><p>This patient likely has an <strong>acute hemolytic transfusion reaction</strong>, a rare but life-threatening reaction typically caused by transfusion of mismatched blood (ie, <strong>ABO incompatibility</strong>), secondary to clerical error.&nbsp; Pathogenesis involves recipient antibodies reacting with donor blood antigens, causing complement fixation and hemolysis as well as a proinflammatory reaction.</p><p>Therefore, patients develop&nbsp;<strong>fever</strong>, chills, and hypotension <strong>within 1 hour</strong> after transfusion initiation; nonspecific&nbsp;<strong>flank pain</strong>&nbsp;is also characteristic.&nbsp;&nbsp;Hemolysis causes&nbsp;<strong>hemoglobinuria</strong>&nbsp;and may lead to <strong>acute renal failure</strong> (due to acute tubular necrosis), <strong>disseminated intravascular coagulation</strong> (eg, bleeding from intravenous site, as in this patient), and shock.&nbsp; Key laboratory findings include a positive direct Coombs test; pink or dark brown plasma and urine (due to hemolysis); and a repeat type and crossmatch confirming a mismatch.</p><p>Management includes immediate cessation of transfusion, aggressive intravenous fluid administration, and supportive care.</p><p><strong>(Choice B)</strong>&nbsp; Delayed hemolytic transfusion reactions result from an anamnestic antibody response to a red blood cell antigen to which the patient was previously sensitized (eg, pregnancy).&nbsp; In contrast to this case, patients typically develop extravascular hemolysis days to weeks after transfusion.</p><p><strong>(Choice C)</strong>&nbsp; Transfusion-transmitted bacterial infection (TTBI), due to bacterial contamination of blood products,&nbsp;is characterized by fever, tachycardia, and hypotension around 30 minutes after transfusion completion.&nbsp; Flank pain is not associated with TTBI.&nbsp; In addition, TTBI most commonly occurs with platelet (rather than red blood cell) transfusions because platelets are stored at room temperature, which increases their susceptibility to bacterial growth.</p><p><strong>(Choice D)</strong>&nbsp; Febrile nonhemolytic transfusion reaction is a common, benign reaction that occurs within 1-6 hours after transfusion due to the release of accumulated cytokines in stored blood.&nbsp; Patients develop transient fever and chills.&nbsp; Hypotension and flank pain do not occur.</p><p><strong>(Choice E)</strong>&nbsp; Individuals with IgA deficiency are at risk of developing anaphylactic reaction to blood products due to preformed anti-IgA antibodies (IgE or IgG) that react against donor blood IgA.&nbsp; Angioedema, hypotension, and respiratory distress (eg, wheezing) occur within minutes after transfusion initiation.&nbsp; This patient&#39;s fever and lack of wheezing or rash make anaphylaxis less likely.</p><p><strong>Educational objective:</strong><br>Acute hemolytic transfusion reaction is an uncommon, life-threatening reaction due to transfusion of mismatched blood (eg, ABO incompatibility), which causes fever, flank pain, and hemoglobinuria within 1 hour of transfusion initiation.&nbsp; Continued hemolysis can lead to acute renal failure, disseminated intravascular coagulation, and shock.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3303,
            "topic": "Blood transfusion",
            "titleId": 3303,
            "title": "Blood transfusion",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "1",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "ABO incompatibility",
                    "choiceNumber": 1,
                    "correctTaken": 8913,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Anamnestic antibody response",
                    "choiceNumber": 2,
                    "correctTaken": 622,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bacterial contamination of the blood product",
                    "choiceNumber": 3,
                    "correctTaken": 297,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cytokine release from the transfused blood product",
                    "choiceNumber": 4,
                    "correctTaken": 3050,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preformed antibodies against IgA",
                    "choiceNumber": 5,
                    "correctTaken": 3547,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2756,2946,true,-1,1*3237,3420,true,-1,1*2426,2482,true,-1,1*281,304,true,-1,1*528,570,true,-1,1*571,585,true,-1,1*491,513,true,-1,1*717,748,true,-1,1*770,837,true,-1,1*877,905,true,-1,1*965,1015,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21404983",
                    "mediaDataId": 0,
                    "title": "Transfusion of blood and blood products: indications and complications.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21404983",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29489247",
                    "mediaDataId": 0,
                    "title": "Transfusion reactions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29489247",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 16429,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1131,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 15161,
            "questionIndex": 16585,
            "questionText": "<p>A 17-year-old boy comes to the office due to fatigue.&nbsp; For the past 6 weeks, the patient has had difficulty attending evening soccer practice due to excessive tiredness and feverishness.&nbsp; He has also had generalized itching but no rash.&nbsp; The patient has no nasal congestion, sore throat, cough, dyspnea, abdominal pain, or diarrhea.&nbsp; He has no significant medical history and takes no medications.&nbsp; Temperature is 38 C (100.4 F), blood pressure is 118/66 mm Hg, and pulse is 86/min.&nbsp; Physical examination shows no scleral icterus or conjunctival pallor.&nbsp; There are several enlarged, nontender, and firm cervical and supraclavicular lymph nodes.&nbsp; Oropharyngeal mucosa and tonsils are normal.&nbsp; The lungs are clear on auscultation, and heart sounds are normal.&nbsp; The abdomen is soft and nontender with no organomegaly.&nbsp; There is no extremity edema or skin rash.&nbsp; Which of the following is most appropriate to establish a diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T51023\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hodgkin lymphoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Bimodal peak incidence: age 15-35 &amp; &gt;60</li><li>Association with EBV in immunosuppression</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Painless lymphadenopathy</li><li>Mediastinal mass</li><li>B symptoms (ie, fever, sweats, weight loss)</li><li>Pruritus</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Lymph node biopsy</li><li>Reed-Sternberg cells on histology</li></ul></td></tr><tr><td colspan=\"2\"><p style=\"margin-left:.25in;\"><strong>EBV</strong> = Epstein-Barr virus.</p></td></tr></tbody></table></div><p>This young patient&#39;s subacute fever, pruritus, fatigue, and painless cervical and supraclavicular lymphadenopathy (LAD) raise strong suspicion for <strong>Hodgkin lymphoma</strong> (HL).&nbsp; Cases generally arise in a bimodal distribution, with peak incidence in patients <strong>age 15-35</strong> and &gt;60.</p><p>HL usually arises in a single lymph node and disseminates to contiguous nodes via the lymphatic and thoracic ducts.&nbsp; Patients generally present with <strong>painless peripheral LAD</strong>, particularly in the <strong>cervical and supraclavicular</strong> chains.&nbsp; Significant mediastinal LAD also occurs in ~50% of cases and may lead to cough, shortness of breath, or chest pain.&nbsp; Most patients have long-standing B symptoms (eg, <strong>fever</strong>, night sweats, weight loss) and <strong>pruritus</strong> (a paraneoplastic process classically associated with HL and likely due to cytokine and interleukin release).</p><p>Individuals with unexplained LAD and findings concerning for malignancy (eg, supraclavicular LAD) require <strong>excisional lymph node biopsy</strong>.&nbsp; Malignant <a href=\"6883\">Reed-Sternberg cells</a> admixed with nonneoplastic inflammatory cells are diagnostic of HL.</p><p><strong>(Choice A)</strong>&nbsp; Antinuclear antibodies are elevated in systemic lupus erythematosus (SLE), which can cause fatigue, fever, and painless peripheral LAD in the cervical, axillary, or inguinal chains.&nbsp; However, supraclavicular LAD is quite uncommon and strongly suggests malignancy.&nbsp; In addition, this patient has no diagnostic features of SLE (eg, malar rash, arthralgia, serositis).</p><p><strong>(Choice C)</strong>&nbsp; Heterophile antibody testing can diagnose infectious mononucleosis, which often causes fatigue, fever, and peripheral LAD (primarily in the cervical chain).&nbsp; However, most patients have sore throat and evidence of pharyngitis on examination, and almost all cases resolve within a month.&nbsp; In addition, LAD tends to be tender (not nontender), and splenomegaly is common.&nbsp; Therefore, heterophile antibody testing is unlikely to establish a diagnosis in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Rapid plasma reagin testing can assist in the diagnosis of syphilis.&nbsp; Secondary syphilis often causes painless peripheral LAD (characteristically in the epitrochlear nodes).&nbsp; However, supraclavicular LAD is uncommon, and most patients have a diffuse, symmetric maculopapular rash that includes the palms and soles.</p><p><strong>(Choice E)</strong>&nbsp; Erythropoietin level testing is part of the diagnostic workup for polycythemia vera, which is a chronic myeloproliferative disorder associated with elevated red blood cell mass.&nbsp; Although this disease is often associated with aquagenic pruritus (itching with warm water exposure), LAD does not generally occur.&nbsp; In addition, most cases occur in patients age &gt;60.</p><p><strong>Educational objective:</strong><br>Hodgkin lymphoma often presents with painless peripheral lymphadenopathy (LAD) in the cervical and/or supraclavicular chains.&nbsp; Patients may also have mediastinal LAD, B symptoms, and pruritus.&nbsp; Diagnosis is usually made with excisional lymph node biopsy (Reed-Sternberg cells).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3439,
            "topic": "Hodgkins lymphoma",
            "titleId": 3439,
            "title": "Hodgkins lymphoma",
            "topicAttributeId": 330684,
            "topicAttribute": "White blood cell disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody assay",
                    "choiceNumber": 1,
                    "correctTaken": 135,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Excisional lymph node biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 3301,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Heterophile antibody testing",
                    "choiceNumber": 3,
                    "correctTaken": 1301,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid plasma reagin",
                    "choiceNumber": 4,
                    "correctTaken": 78,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum erythropoietin level testing",
                    "choiceNumber": 5,
                    "correctTaken": 380,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "243,251,true,-1,1*262,279,true,-1,1*83,99,true,-1,1*1046,1165,true,-1,1*1606,1676,true,-1,1*2092,2162,true,-1,1*2337,2440,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "245",
                    "mediaDataId": 0,
                    "title": "Hodgkin lymphoma",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 139,
            "othersAvgTimeSpent": 84,
            "notes": null,
            "peopleTaken": 5195,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 570,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 11320,
            "questionIndex": 12473,
            "questionText": "<p>A 64-year-old woman comes to the office due to a bitemporal headache that has slowly worsened over the past week.&nbsp; The patient has also had dizziness, blurry vision, and tingling and numbness of her feet.&nbsp; She has had no fever or jaw pain.&nbsp; The patient has a history of hypertension, for which she takes lisinopril.&nbsp; She does not use tobacco or alcohol.&nbsp; Temperature is 37.2 C (99.0 F), blood pressure is 140/90 mm Hg, pulse is 70/min, and respirations are 16/min.&nbsp; Physical examination shows moist mucous membranes, normal tympanic membranes, and no sinus or temporal area tenderness.&nbsp; Bilateral pupils are equal and reactive.&nbsp; Visual acuity is decreased in both eyes, and funduscopic examination reveals dilated, segmented, and tortuous retinal veins.&nbsp; Facial sensation and strength are normal.&nbsp; Bilateral upper and lower extremity muscle strength is normal.&nbsp; There is decreased pinprick sensation and loss of ankle reflex bilaterally in the feet.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>11.2 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>180,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>8,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td>9.6 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total protein</td><td>10.5 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td>3.7 g/dL</td></tr><tr><td colspan=\"2\"></td></tr><tr><td>Erythrocyte sedimentation rate</td><td>80 mm/hr</td></tr></tbody></table><p>Which of the following is the best next diagnostic study for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t81585\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Waldenstr</strong><strong>&ouml;m macroglobulinemia vs multiple myeloma</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Waldenstr&ouml;m macroglobulinemia</strong></p></td><td><p align=\"center\"><strong>Multiple myeloma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Major manifestations</strong></p></td><td><ul><li>Hyperviscosity syndrome</li><li>Neuropathy</li><li>Bleeding</li><li>Hepatosplenomegaly</li><li>Lymphadenopathy</li></ul></td><td><ul><li>Osteolytic lesions/fractures</li><li>Anemia</li><li>Hypercalcemia</li><li>Renal insufficiency</li></ul></td></tr><tr><td><p align=\"center\"><strong>Monoclonal antibody</strong></p></td><td><ul><li>IgM</li></ul></td><td><ul><li>IgG, IgA, light chains</li></ul></td></tr><tr><td><p align=\"center\"><strong>Peripheral smear</strong></p></td><td><ul><li>Rouleaux</li></ul></td><td><ul><li>Rouleaux</li></ul></td></tr><tr><td><p align=\"center\"><strong>Bone marrow biopsy</strong></p></td><td><ul><li>&gt;10% clonal B cells</li></ul></td><td><ul><li>&gt;10% clonal plasma cells</li></ul></td></tr></tbody></table></div></p><p>This patient with a week of headaches, dizziness, and blurry vision has a large gamma gap (difference between total protein and albumin) and &#x22;sausage-link&#x22; retinal changes, suggesting hyperviscosity syndrome due to <strong>Waldenstr&ouml;m macroglobulinemia (WM)</strong>.</p><p>WM is a B-cell malignancy characterized by the excessive production of <strong>monoclonal IgM antibody</strong>.&nbsp; IgM is a large immunoglobulin, and high levels can clog the microvasculature, resulting in <strong>hyperviscosity syndrome</strong>.&nbsp; Symptoms typically include vision changes, headaches, vertigo, dizziness, and/or ataxia; rarely, stroke or coma may occur.&nbsp; Other IgM-mediated conditions commonly seen in patients with WM include <strong>peripheral neuropathy</strong>, cryoglobulinemia, and renal insufficiency.&nbsp; Physical examination typically shows <strong>&#x22;sausage-link&#x22;</strong> (dilated, segmented, tortuous) retinal veins, and laboratory studies usually reveal anemia, a <strong>gamma gap</strong>, and elevated erythrocyte sedimentation rate (ESR).</p><p>The screening test for WM is <strong>serum protein electrophoresis (SPEP)</strong>, which can identify a monoclonal IgM spike.&nbsp; If positive, bone marrow biopsy is performed (lymphocytic infiltration with certain immunophenotype markers).&nbsp; This patient would also require serum viscosity testing as urgent plasmapheresis may be required.</p><p><strong>(Choice A)</strong>&nbsp; Antineutrophil cytoplasmic antibody is associated with microscopic polyangiitis and granulomatosis with polyangiitis.&nbsp; Patients often have ear, nose, throat, upper airway, and renal manifestations.&nbsp; These conditions are usually associated with a marked elevation in ESR, but a sizable gamma gap and &#x22;sausage-link&#x22; retinal veins would be uncommon.</p><p><strong>(Choice B)</strong>&nbsp; Diabetes mellitus is associated with elevated hemoglobin A1c levels and commonly causes peripheral neuropathy and retinopathy.&nbsp; Funduscopic examination in patients with diabetic retinopathy typically reveals hemorrhages and cotton wool spots (not &#x22;sausage-link&#x22; changes).&nbsp; In addition, a large gamma gap would be atypical.</p><p><strong>(Choice C)</strong>&nbsp; MRI of the brain may be useful for multiple sclerosis, which can cause vision changes, sensory symptoms, and elevated ESR.&nbsp; However, this patient with &#x22;sausage-link&#x22; retinal changes and elevated gamma gap has neurologic symptoms likely due to hyperviscosity syndrome.&nbsp; She requires a SPEP and serum viscosity measurement; MRI of the brain is likely to be normal.</p><p><strong>(Choice E)</strong>&nbsp; Temporal artery biopsy helps diagnose giant cell arteritis, which usually manifests in older individuals with headaches, visual changes, jaw claudication, fever, anemia, and elevated ESR.&nbsp; This patient has peripheral neuropathy, a gamma gap, and no jaw symptoms, making WM more likely.</p><p><strong>Educational objective:</strong><br>Waldenstr&ouml;m macroglobulinemia is a B-cell neoplasm associated with elevated monoclonal IgM.&nbsp; High levels of IgM may cause hyperviscosity syndrome (vision changes, headaches, vertigo, dizziness, ataxia), peripheral neuropathy, cryoglobulinemia, and/or renal insufficiency.&nbsp; Diagnosis requires serum protein electrophoresis and bone marrow biopsy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 9166,
            "topic": "Waldenstrm macroglobulinemia",
            "titleId": 9166,
            "title": "Waldenstrm macroglobulinemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antineutrophil cytoplasmic antibodies",
                    "choiceNumber": 1,
                    "correctTaken": 1126,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemoglobin A1c level",
                    "choiceNumber": 2,
                    "correctTaken": 3278,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the brain",
                    "choiceNumber": 3,
                    "correctTaken": 1981,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum protein electrophoresis",
                    "choiceNumber": 4,
                    "correctTaken": 5695,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Temporal artery biopsy",
                    "choiceNumber": 5,
                    "correctTaken": 3606,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "185,228,true,-1,1*400,419,true,-1,1*420,444,true,-1,1*1602,1701,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 61,
            "othersAvgTimeSpent": 94,
            "notes": null,
            "peopleTaken": 15686,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 36,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 518,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 4193,
            "questionIndex": 4193,
            "questionText": "<p>A 25-year-old woman, gravida 2 para 1, at 8 weeks gestation comes to the physician to initiate prenatal care.&nbsp; Her blood type is O negative and the father&#39;s blood type is O positive.&nbsp; Her first pregnancy was significant for placental abruption at the time of delivery.&nbsp; She received the standard dose of anti-D immune globulin at 28 weeks during her first pregnancy and again 1 day postpartum.&nbsp; The patient has no medical problems and no history of blood transfusions.&nbsp; Her anti-D antibody titer is currently 1:32.&nbsp; Which of the following is the most likely explanation for this patient&#39;s finding?</p>",
            "questionHeader": "",
            "explanationText": "<p>This woman&#39;s O-negative blood type indicates that she is Rh negative, and the anti-D antibody titer of 1:32 reflects that she is alloimmunized (ie, sensitized).&nbsp; <a href=\"1151\">Alloimmunization</a> occurs when the mother is Rh negative and has an Rh-positive fetus.&nbsp; Her first pregnancy, especially the placental abruption, put her at risk for alloimmunization.&nbsp; To prevent the maternal immune system from developing anti-D antibodies, <strong>anti-D immune globulin</strong> is first administered at <strong>28 weeks gestation</strong> and repeated <strong>within 72 hours of delivery</strong>.</p><p>A standard dose of 300 &micro;g at 28 weeks gestation can usually prevent alloimmunization.&nbsp; However, ~50% of Rh-negative women will need a higher dose after delivery, placental abruption, or procedures.&nbsp; The <a href=\"1165\"><strong>Kleihauer-Betke (KB)</strong> test</a> is commonly used to determine the dose.&nbsp; Red blood cells from the maternal circulation are fixed on a slide.&nbsp; The slide is exposed to an acidic solution and adult hemoglobin lyses, leaving &#x22;ghost&#x22; cells.&nbsp; The dose of anti-D immune globulin is calculated from the percentage of remaining fetal hemoglobin.</p><p><strong>(Choice B)</strong>&nbsp; The standard dose of anti-D immune globulin at 28 weeks gestation in an uncomplicated pregnancy is usually adequate as the risk of alloimmunization is very low before this time.&nbsp; However, if the patient developed placental abruption earlier in pregnancy, the KB test should be performed to determine whether a higher dose is indicated.&nbsp; Other indications for anti-D immune globulin include amniocentesis, chorionic villus sampling, and external cephalic version.</p><p><strong>(Choice C)</strong>&nbsp; Prophylaxis between pregnancies is rarely necessary.&nbsp; It is possible but uncommon for sensitization to occur from inadvertent intravenous transfusion of Rh-positive blood due to routine blood bank cross-matching.&nbsp; Sensitization could also occur during an unrecognized spontaneous abortion of an Rh-positive fetus, but most women would experience bleeding.</p><p><strong>(Choice D)</strong>&nbsp; Delayed administration of anti-D immune globulin after 72 hours postpartum may allow sensitization to occur.&nbsp; However, the timing of this patient&#39;s anti-D immune globulin within 72 hours after delivery is appropriate.</p><p><strong>(Choice E)</strong>&nbsp; The patient&#39;s antibody titer reflects Rh alloimmunization that developed from the first pregnancy.&nbsp; If an undisclosed new partner is Rh positive, the fetus may also be Rh positive and at risk for hemolytic disease of the newborn.&nbsp; However, if an undisclosed new partner is Rh negative, the fetus will not be at risk for hemolysis.</p><p><strong>Educational objective:</strong><br>Anti-D immune globulin should be administered to any Rh D-negative mother who delivers an Rh D-positive baby.&nbsp; The standard dose is usually adequate at 28 weeks gestation.&nbsp; After delivery or procedures, the Kleihauer-Betke test is used to determine whether a higher dose is needed due to the increased risk of fetal blood cells entering the maternal circulation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 15363,
            "topic": "Rhesus alloimmunization",
            "titleId": 15363,
            "title": "Rhesus alloimmunization",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Inadequate dose of anti-D immune globulin after her first delivery",
                    "choiceNumber": 1,
                    "correctTaken": 75057,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inadequate dose of anti-D immune globulin during her first pregnancy",
                    "choiceNumber": 2,
                    "correctTaken": 20041,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No anti-D immune globulin prophylaxis between the pregnancies",
                    "choiceNumber": 3,
                    "correctTaken": 14687,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Premature administration of anti-D immune globulin after her first pregnancy",
                    "choiceNumber": 4,
                    "correctTaken": 12650,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Undisclosed new paternity during this pregnancy",
                    "choiceNumber": 5,
                    "correctTaken": 5823,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1439,1563,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "10458556",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin  prevention of Rh D alloimmunization.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/10458556",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 133,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 128258,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 739,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 4672,
            "questionIndex": 4672,
            "questionText": "<p>A 29-year-old man comes to the emergency department following a motor vehicle collision.&nbsp; The patient is alert and oriented; trauma evaluation shows an unstable pelvis with a pelvic fracture confirmed on imaging.&nbsp; He receives multiple boluses of intravenous fluids and is started on a packed red blood cell transfusion.&nbsp; A few minutes after the transfusion starts, the patient develops shortness of breath and has an episode of nonbloody emesis.&nbsp; He has no chest or back pain.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 88/40 mm Hg, pulse is 140/min, and respirations are 30/min.&nbsp; Pulse oximetry is 86% on 100% oxygen provided via a nonrebreather mask.&nbsp; The patient answers questions in short phrases.&nbsp; Lung examination shows decreased breath sounds bilaterally.&nbsp; Pulses are weak.&nbsp; Urinalysis is normal.&nbsp; Which of the following is the most likely cause of this patient&#39;s respiratory distress?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t48544\"><table class=\"table-default-style table-footer-only-style\" style=\"width:89.16%\"><tbody><tr><td colspan=\"4\" style=\"width:100.0%\"><p align=\"center\"><strong>Transfusion reactions associated with hypotension</strong></p></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Reaction</strong></p></td><td style=\"width:17.2%\"><p align=\"center\"><strong>Onset*</strong></p></td><td style=\"width:23.52%\"><p align=\"center\"><strong>Cause</strong></p></td><td style=\"width:35.92%\"><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Anaphylaxis</strong></p></td><td style=\"width:17.2%\"><p align=\"center\">Seconds to minutes</p></td><td style=\"width:23.52%\"><p align=\"center\">Recipient anti-IgA antibodies</p></td><td style=\"width:35.92%\"><ul><li>Shock, angioedema/urticaria &amp; respiratory distress</li></ul></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Transfusion-related acute lung injury</strong></p></td><td style=\"width:17.2%\"><p align=\"center\">Minutes to hours</p></td><td style=\"width:23.52%\"><p align=\"center\">Donor antileukocyte antibodies</p></td><td style=\"width:35.92%\"><ul><li>Respiratory distress &amp; noncardiogenic pulmonary edema</li><li>Bilateral pulmonary infiltrates</li></ul></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Acute hemolysis</strong></p></td><td style=\"width:17.2%\"><p align=\"center\">Minutes to hours</p></td><td style=\"width:23.52%\"><p align=\"center\">ABO incompatibility</p></td><td style=\"width:35.92%\"><ul><li>Fever, flank pain, hemoglobinuria &amp; DIC</li></ul></td></tr><tr><td style=\"width:23.36%\"><p align=\"center\"><strong>Bacterial sepsis</strong></p></td><td style=\"width:17.2%\"><p align=\"center\">Minutes to hours</p></td><td style=\"width:23.52%\"><p align=\"center\">Bacterial contamination of donor product</p></td><td style=\"width:35.92%\"><ul><li>Fever, chills, septic shock &amp; DIC</li></ul></td></tr><tr><td colspan=\"4\" style=\"width:100.0%\"><p>*Time after transfusion initiation.</p><p><strong>DIC</strong> = disseminated intravascular coagulation.</p></td></tr></tbody></table></div><p>This patient&#39;s rapid deterioration immediately after blood transfusion initiation is consistent with an <strong>anaphylactic reaction</strong>.&nbsp; Anaphylaxis occurs <strong>seconds to minutes</strong> after initiation of transfusion due to massive histamine release.&nbsp; Symptoms include <strong>respiratory distress</strong> (eg, dyspnea, hypoxia), angioedema, and <strong>hypotension</strong>.&nbsp; Wheezing is often appreciated, although decreased breath sounds can occur with severe bronchospasm preventing air entry.&nbsp; Vomiting and urticaria may also be present.&nbsp; Without treatment, symptoms can rapidly progress to respiratory failure and <strong>shock</strong>.</p><p>The first step in management is to immediately <strong>stop the transfusion</strong> and administer <strong>intramuscular epinephrine</strong>.&nbsp; Bronchodilators and antihistamines are typically also administered.&nbsp; In some cases, hemodynamic and respiratory support (eg, vasopressors, mechanical ventilation) may be required.</p><p>Patients with <strong>IgA deficiency</strong> are at <strong>higher risk</strong> of anaphylactic transfusion reaction because they may have <strong>anti-IgA antibodies</strong>&nbsp;that react with donor blood IgA and contribute to histamine release.&nbsp; Although IgA deficiency can present with recurrent sinopulmonary infections, it is often asymptomatic and may be diagnosed only after an anaphylactic transfusion reaction.&nbsp; Future transfusions should include IgA-deficient plasma and washed red blood cell products.</p><p><strong>(Choice B)</strong>&nbsp; Aspiration pneumonitis is caused by gastric acid aspiration, most commonly in the setting of altered mental status or dysphagia.&nbsp; It can lead to hypoxia but typically causes crackles and would be unexpected in a patient with no history of aspiration.</p><p><strong>(Choice C)</strong>&nbsp; Fat embolism can be a complication of femoral or pelvic fracture and typically presents with respiratory distress and hypoxia.&nbsp; However, patients typically develop symptoms &gt;24 hours after injury and often also have altered consciousness and petechial rash.</p><p><strong>(Choice D)</strong>&nbsp; Acute hemolytic transfusion reaction from ABO incompatibility is rare but can occur due to clerical errors (eg, misidentification of patient).&nbsp; Patients are hypotensive but also have fever, flank pain, and hemoglobinuria.</p><p><strong>(Choice E)</strong>&nbsp; Febrile nonhemolytic transfusion reaction, the most common adverse reaction to transfusion, occurs within 1-6 hours of transfusion.&nbsp; During blood storage, leukocytes release cytokines that, when transfused, cause transient fevers, chills, and malaise.&nbsp; Febrile nonhemolytic transfusion reaction is unlikely given this patient&#39;s respiratory distress, shock, and lack of fever.</p><p><strong>(Choice F)</strong>&nbsp; Transfusion-associated circulatory overload is characterized by pulmonary edema due to volume overload.&nbsp; Patients have respiratory distress and hypoxia, but hypotension would not be expected (many patients are hypertensive).</p><p><strong>Educational objective:</strong><br>Anaphylactic transfusion reaction is characterized by a rapid onset (seconds to minutes) of respiratory distress and hypotension, which quickly progresses to respiratory failure and shock.&nbsp; Acute management includes immediate transfusion cessation and administration of epinephrine.&nbsp; IgA-deficient patients are at increased risk.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3303,
            "topic": "Blood transfusion",
            "titleId": 3303,
            "title": "Blood transfusion",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "1",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anaphylactic reaction",
                    "choiceNumber": 1,
                    "correctTaken": 8057,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aspiration pneumonitis",
                    "choiceNumber": 2,
                    "correctTaken": 80,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fat embolism",
                    "choiceNumber": 3,
                    "correctTaken": 1785,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemolytic reaction from ABO incompatibility",
                    "choiceNumber": 4,
                    "correctTaken": 1751,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reaction from cytokines in transfused blood",
                    "choiceNumber": 5,
                    "correctTaken": 3291,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Volume overload",
                    "choiceNumber": 6,
                    "correctTaken": 817,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1011,1133,true,-1,1*1135,1178,true,-1,1*1923,2015,true,-1,1*2027,2278,true,-1,1*2419,2548,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21404983",
                    "mediaDataId": 0,
                    "title": "Transfusion of blood and blood products: indications and complications.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21404983",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 170,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 15781,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 741,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 4402,
            "questionIndex": 4402,
            "questionText": "<p>A 34-year-old man is brought to the emergency room after being involved in a motor vehicle collision.&nbsp; He suffered blunt abdominal trauma and bilateral femur fractures.&nbsp; Medical history is unremarkable.&nbsp; Blood pressure is 80/40 mm Hg and pulse is 110/min.&nbsp; He receives several units of packed red blood cells.&nbsp; Once stabilized, the patient develops a tingling sensation in his toes and fingers.&nbsp; His serum calcium level is noted to be 7.2 mg/dL.&nbsp; Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient is experiencing paresthesias due to <strong>hypocalcemia</strong>.&nbsp; He has had significant blood loss as a result of his injuries and has received <strong>packed red blood cells</strong> as part of the resuscitation efforts.&nbsp; Prior to storage, whole blood (for transfusions) is generally mixed with solutions containing <strong>citrate anticoagulant</strong>.&nbsp; Packed cells derived from these whole blood collections also contain citrate.&nbsp; Infused citrate can <strong>chelate serum calcium</strong>, causing hypocalcemia. This is most likely after <strong>massive transfusions</strong> of the equivalent of more than one blood volume over 24 hours.</p><p><b>(Choice C)</b>&nbsp; Stored red blood cells gradually lose intracellular potassium to the surrounding solution.&nbsp; This mechanism has the potential to cause hyperkalemia, but not hypocalcemia.</p><p><b>Educational objective:</b><br>Patients who have received the equivalent of more than one blood volume of blood transfusions or packed red blood cells over 24 hours may develop elevated plasma levels of citrate, a substance added to stored blood.&nbsp; Citrate chelates calcium and magnesium and may reduce their plasma levels, causing paresthesias.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 2731,
            "topic": "Hypocalcemia",
            "titleId": 2731,
            "title": "Hypocalcemia",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Increased renal tubular secretion of calcium",
                    "choiceNumber": 1,
                    "correctTaken": 15844,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Calcium chelation by a substance in the transfused blood",
                    "choiceNumber": 2,
                    "correctTaken": 257303,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Electrolyte leakage from red blood cells during pre-transfusion storage",
                    "choiceNumber": 3,
                    "correctTaken": 17289,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antibody-mediated red blood cell membrane damage",
                    "choiceNumber": 4,
                    "correctTaken": 11299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parathyroid gland suppression due to fluid overload",
                    "choiceNumber": 5,
                    "correctTaken": 6228,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "496,606,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 24,
            "othersAvgTimeSpent": 42,
            "notes": null,
            "peopleTaken": 307963,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 84,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 231,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 4160,
            "questionIndex": 4160,
            "questionText": "<p>A 55-year-old man is hospitalized after a massive hemorrhage from a duodenal ulcer.&nbsp; The bleeding is stopped with endoscopic manipulation.&nbsp; The patient receives 2 L of intravenous fluids, followed by 2 units of packed red blood cells.&nbsp; Two hours after the transfusion is started, he develops chills and malaise.&nbsp; Temperature is 38.7 C (101.7 F), blood pressure is 120/76 mm Hg, pulse is 100/min, and respirations are 20/min.&nbsp; The transfusion is stopped, and the patient is given acetaminophen.&nbsp; Direct antiglobulin and plasma-free hemoglobin level tests are negative.&nbsp; Urinalysis is within normal limits.&nbsp; The symptoms resolve within 6 hours of transfusion discontinuation.&nbsp; Which of the following is the best procedure for preventing this type of transfusion reaction?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7207\" src=\"https://www.uworld.com/media/L15372.jpg\" ></p><p><strong>Febrile nonhemolytic transfusion reaction</strong> (FNHTR), the <strong>most common</strong> adverse transfusion reaction, is a <strong>benign</strong> occurrence caused by cytokine release from leukocytes within the donor blood product.</p><p>During preparation of blood products, whole blood is separated into red blood cells and plasma.&nbsp; However, small amounts of <strong>leukocyte</strong> debris remain in the red cell concentrate.&nbsp; During blood storage, these leukocytes can <strong>release cytokines</strong>, which when transfused can cause <strong>transient fever</strong>, <strong>chills</strong>, and <strong>malaise</strong> within <strong>1-6 hours</strong> of transfusion initiation.&nbsp; Management includes transfusion cessation (to exclude other serious reactions) and antipyretic administration.</p><p>Risk of recurrent FNHTR is high after a first episode, and <strong>prevention</strong> is best achieved by using leukoreduced blood products for future transfusions.&nbsp; <strong>Leukoreduction</strong> involves filtering out most of the leukocytes after blood collection but before blood storage, thereby minimizing cytokine production within the packed red blood cell product.&nbsp; Leukoreduction also reduces the risk of human leukocyte antigen alloimmunization and transmission of cytomegalovirus (which typically resides in leukocytes).&nbsp; Many facilities empirically leukoreduce all blood products, but this process is not universal.</p><p><strong>(Choice A)</strong>&nbsp; Careful cross-matching of blood prevents acute hemolytic transfusion reaction (AHTR), which is caused by mismatched donor and recipient blood.&nbsp; Symptoms include chills, flank pain, and gross hematuria within an hour of transfusion.&nbsp; Unlike this patient, those with AHTR have a positive direct antiglobulin (Coombs) test, increased plasma-free hemoglobin, and hemoglobinuria.</p><p><strong>(Choices B and E)</strong>&nbsp; Citrate, which binds ionized calcium, is the main anticoagulant used for blood product storage and can cause hypocalcemia if a massive transfusion is required (eg, cardiac surgery).&nbsp; Calcium gluconate infusion is used to prevent or treat severe hypocalcemia.&nbsp; Similarly, warming the blood product is recommended during rapid, massive transfusion to prevent hypothermia and arrhythmia.</p><p><strong>(Choice C)</strong>&nbsp; Premedication with antipyretics or antihistamines (eg, diphenhydramine), which was previously used in some centers,&nbsp;has been found not to reduce the incidence of FNHTR in several studies.</p><p><strong>Educational objective:</strong><br>Febrile nonhemolytic transfusion reaction (FNHTR) is the most common adverse reaction and is caused by release of cytokines from leukocytes in the stored blood product.&nbsp; Symptoms develop within 1-6 hours and include transient fever, chills, and malaise.&nbsp; Leukoreduction of donor blood helps prevent FNHTR.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 3303,
            "topic": "Blood transfusion",
            "titleId": 3303,
            "title": "Blood transfusion",
            "topicAttributeId": 330678,
            "topicAttribute": "Transfusion medicine",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Careful cross-matching of blood",
                    "choiceNumber": 1,
                    "correctTaken": 1824,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Infusing calcium gluconate",
                    "choiceNumber": 2,
                    "correctTaken": 749,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Premedicating with diphenhydramine",
                    "choiceNumber": 3,
                    "correctTaken": 2900,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Using a leukoreduced blood product",
                    "choiceNumber": 4,
                    "correctTaken": 9197,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Warming the blood product",
                    "choiceNumber": 5,
                    "correctTaken": 1071,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2088,2277,true,-1,1*840,1188,true,-1,1*1964,2077,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20376259",
                    "mediaDataId": 0,
                    "title": "Leukoreduced blood components: advantages and strategies for its implementation in developing countries.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20376259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 40,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 15748,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 410,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 2621,
            "questionIndex": 2621,
            "questionText": "<p>A 71-year-old man with metastatic prostate cancer comes to the office due to progressively worsening back pain.&nbsp; The patient reports pain of 5 on a 10-point scale.&nbsp; The pain is notably worse with movement and limits his activity.&nbsp; He reports no lower extremity weakness or numbness and no bladder or bowel dysfunction.&nbsp; He is taking ibuprofen 3 or 4 times a day, and his pain is not controlled.&nbsp; The patient takes androgen deprivation therapy and has also received palliative radiotherapy for multiple lumbar spine metastases recently.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 140/86 mm Hg, and pulse is 88/min.&nbsp; Lower extremity motor strength, deep tendon reflexes, and sensation are normal.&nbsp; Which of the following is the most appropriate initial therapy for this patient&#39;s pain?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"5984\" src=\"https://www.uworld.com/media/highresdefault/L8818.png\"  ></p><p>This patient has <strong>bone metastases with progressive pain</strong> despite specific cancer-directed treatment (ie, androgen deprivation therapy, radiotherapy).</p><p>Mild cancer-related pain can usually be managed with nonopioid analgesics (eg, acetaminophen, nonsteroidal anti-inflammatory drugs [NSAIDs]).&nbsp; However, if nonopioid interventions are ineffective, as in this patient with <strong>moderate to severe</strong> (eg, &gt;4/10) pain limiting activity despite NSAIDs, <strong>short-acting opioids</strong> (eg, oxycodone, morphine) should be offered.&nbsp; Short-acting opioids are safe and well tolerated when taken as directed, and the dose and schedule can be easily adjusted to the patient&#39;s pain pattern.</p><p>Once short-acting opioids have been started, if the patient&#39;s pain requires frequent dosing or if bedtime doses do not provide adequate relief through the night, conversion to long-acting opioids can improve convenience (eg, less frequent dosing) and help stabilize pain control (eg, steady drug levels).&nbsp; Options include extended-release morphine and transdermal fentanyl.&nbsp; However, due to the risk of respiratory depression, patients not receiving opioids should generally <strong>not</strong> be started on <strong>long-acting opioids initially (Choice E)</strong>.</p><p>Rather, they should have a trial of short-acting opioids that can be readily titrated and then converted to a long-acting opioid dose that can be safely tolerated.&nbsp; This approach provides adequate analgesia while avoiding the risk of &#x22;overshoot&#x22; from the accumulation of long-acting opioids prior to reaching their steady state.&nbsp; Even after transition to a long-acting formulation, short-acting opioids should still be available for rescue treatment of breakthrough pain.</p><p><strong>(Choice B)</strong>&nbsp; Naproxen has a longer duration of action than ibuprofen and can be used in patients who require frequent dosing.&nbsp; Switching from one NSAID to another can be considered for patients with mild pain, but this patient&#39;s activity-limiting pain warrants a trial of opioids.</p><p><strong>(Choice C)</strong>&nbsp; Systemic glucocorticoids (eg, dexamethasone) are used urgently for the treatment of malignant neurologic compromise (eg, spinal cord compression).&nbsp; They are also sometimes used as adjunctive therapy in patients who have bone pain without neurologic deficits if there is incomplete improvement on opioid therapy alone.</p><p><strong>(Choice D)</strong>&nbsp; Topical capsaicin is useful for mild to moderate joint and neuropathic pain (eg, postherpetic neuralgia); it is unlikely to relieve metastatic bone pain.</p><p><strong>Educational objective:</strong><br>Mild cancer-related pain can usually be managed with nonopioid analgesics.&nbsp; However, if initial interventions are not effective, intermittent doses of short-acting opioids should be offered.&nbsp; If the pain requires frequent dosing or if bedtime dosing does not provide relief through the night, then conversion to a long-acting opioid is helpful.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 206,
            "system": "Hematology & Oncology",
            "topicId": 24773,
            "topic": "Chronic pain",
            "titleId": 24773,
            "title": "Chronic pain",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Short-acting opioid",
                    "choiceNumber": 1,
                    "correctTaken": 7456,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substitution of ibuprofen with naproxen",
                    "choiceNumber": 2,
                    "correctTaken": 1504,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systemic glucocorticoid",
                    "choiceNumber": 3,
                    "correctTaken": 1233,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Topical capsaicin",
                    "choiceNumber": 4,
                    "correctTaken": 769,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transdermal fentanyl patch",
                    "choiceNumber": 5,
                    "correctTaken": 4725,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27105021",
                    "mediaDataId": 0,
                    "title": "Oral morphine for cancer pain.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27105021",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29603142",
                    "mediaDataId": 0,
                    "title": "Optimal pain management for patients with cancer in the modern era.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29603142",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 66,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 15687,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 12,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}